|
OMIM |
Link |
Information gain |
01 |
|
apnea, obstructive sleep
|
[NCBI]
|
0.00321022
|
|
|
HPC10
|
[NCBI]
|
0.00219335
|
|
|
MAFD6
|
[NCBI]
|
0.00176054
|
|
|
G6PD
|
[NCBI]
|
0.00154288
|
|
|
RA
|
[NCBI]
|
0.00129768
|
|
|
diabetes mellitus, insulin-dependent, 2
|
[NCBI]
|
0.00123068
|
|
|
musk, inability to smell
|
[NCBI]
|
0.00109449
|
|
|
CHDS8
|
[NCBI]
|
0.00109449
|
|
|
IBD5
|
[NCBI]
|
0.00098595
|
|
|
stature quantitative trait locus 6
|
[NCBI]
|
0.000933659
|
|
|
SLE
|
[NCBI]
|
0.000771777
|
|
|
diabetes mellitus, noninsulin-dependent, 3
|
[NCBI]
|
0.000742025
|
|
|
knobloch syndrome, type ii
|
[NCBI]
|
0.000727204
|
|
|
DA4
|
[NCBI]
|
0.000727204
|
|
|
HFA
|
[NCBI]
|
0.000727204
|
|
|
plasmodium falciparum fever episodes quantitative trait locus 1
|
[NCBI]
|
0.000727204
|
|
|
BMND7
|
[NCBI]
|
0.000727204
|
|
|
hypotrichosis simplex
|
[NCBI]
|
0.000727204
|
|
|
gene expression, variation in, quantitative trait locus on chromosome 20
|
[NCBI]
|
0.000727204
|
|
|
BMND6
|
[NCBI]
|
0.000727204
|
|
|
bone size quantitative trait locus 2
|
[NCBI]
|
0.000727204
|
|
|
gene expression, variation in, quantitative trait locus on chromosome 14
|
[NCBI]
|
0.000727204
|
|
|
maxillofacial dysostosis
|
[NCBI]
|
0.000727204
|
|
|
MENAQ1
|
[NCBI]
|
0.000727204
|
|
|
ATFB5
|
[NCBI]
|
0.000727204
|
|
|
HBB
|
[NCBI]
|
0.000683046
|
|
|
cluster headache, familial
|
[NCBI]
|
0.000675756
|
|
|
prostate cancer, hereditary, 8
|
[NCBI]
|
0.000620586
|
|
|
autism
|
[NCBI]
|
0.000562815
|
|
|
FSHMD1A
|
[NCBI]
|
0.000534497
|
|
|
HPCX
|
[NCBI]
|
0.000532486
|
|
|
EGF
|
[NCBI]
|
0.000513612
|
|
|
HBA1
|
[NCBI]
|
0.000502633
|
|
|
alzheimer disease 6
|
[NCBI]
|
0.000496312
|
|
|
CLN9
|
[NCBI]
|
0.000466298
|
|
|
high density lipoprotein cholesterol level quantitative trait locus 4
|
[NCBI]
|
0.000466298
|
|
|
primary lateral sclerosis, adult
|
[NCBI]
|
0.000466298
|
|
|
malaria, mild, susceptibility to
|
[NCBI]
|
0.000466298
|
|
|
FSHMD1B
|
[NCBI]
|
0.000466298
|
|
|
angioma, hereditary neurocutaneous
|
[NCBI]
|
0.000466298
|
|
|
rosselli-gulienetti syndrome
|
[NCBI]
|
0.000466298
|
|
|
CPL
|
[NCBI]
|
0.000466298
|
|
|
orthostatic hypotensive disorder, streeten type
|
[NCBI]
|
0.000466298
|
|
|
OFC1
|
[NCBI]
|
0.000410675
|
|
|
pyruvate kinase deficiency of red cells
|
[NCBI]
|
0.000400903
|
|
|
AUTS7
|
[NCBI]
|
0.000370505
|
|
|
HSCR9
|
[NCBI]
|
0.000370505
|
|
|
migraine with or without aura, susceptibility to, 3
|
[NCBI]
|
0.000370505
|
|
|
osteogenesis imperfecta, type v
|
[NCBI]
|
0.000370505
|
|
|
pentosuria
|
[NCBI]
|
0.000370505
|
|
|
pelvic organ prolapse
|
[NCBI]
|
0.000370505
|
|
|
ophthalmoplegia, familial static
|
[NCBI]
|
0.000370505
|
|
|
gangliosidosis, gm2, type iii, or juvenile type
|
[NCBI]
|
0.000370505
|
|
|
bone size quantitative trait locus 1
|
[NCBI]
|
0.000370505
|
|
|
migraine without aura, susceptibility to, 4
|
[NCBI]
|
0.000370505
|
|
|
stature quantitative trait locus 8
|
[NCBI]
|
0.000370505
|
|
|
osteogenesis imperfecta, type vi
|
[NCBI]
|
0.000370505
|
|
|
dianzani autoimmune lymphoproliferative disease
|
[NCBI]
|
0.000370505
|
|
|
OFC2
|
[NCBI]
|
0.000370505
|
|
|
TNF
|
[NCBI]
|
0.000352601
|
|
|
MC1R
|
[NCBI]
|
0.000351451
|
|
|
TTR
|
[NCBI]
|
0.000340416
|
|
|
NGFB
|
[NCBI]
|
0.000319285
|
|
|
RP6
|
[NCBI]
|
0.00030981
|
|
|
HBFQTL3
|
[NCBI]
|
0.00030981
|
|
|
antipyrine metabolism
|
[NCBI]
|
0.00030981
|
|
|
gout susceptibility 1
|
[NCBI]
|
0.00030981
|
|
|
dandy-walker malformation with mental retardation, basal ganglia disease, and seizures
|
[NCBI]
|
0.00030981
|
|
|
duodenal ulcer, hyperpepsinogenemic i
|
[NCBI]
|
0.00030981
|
|
|
epilepsy, nocturnal frontal lobe, type 2
|
[NCBI]
|
0.00030981
|
|
|
CELIAC6
|
[NCBI]
|
0.00030981
|
|
|
RP24
|
[NCBI]
|
0.00030981
|
|
|
PN
|
[NCBI]
|
0.00030981
|
|
|
oligosynaptic infertility
|
[NCBI]
|
0.00030981
|
|
|
kbg syndrome
|
[NCBI]
|
0.00030981
|
|
|
obesity
|
[NCBI]
|
0.000306771
|
|
|
SCZD3
|
[NCBI]
|
0.00030531
|
|
|
PTH
|
[NCBI]
|
0.000278357
|
|
|
VEGF
|
[NCBI]
|
0.000274472
|
|
|
alport syndrome, autosomal dominant
|
[NCBI]
|
0.000273551
|
|
|
PRL
|
[NCBI]
|
0.000272454
|
|
|
spinal muscular atrophy, childhood, proximal, autosomal dominant
|
[NCBI]
|
0.000265783
|
|
|
tongue, pigmented fungiform papillae of
|
[NCBI]
|
0.000265783
|
|
|
OPA4
|
[NCBI]
|
0.000265783
|
|
|
ETM2
|
[NCBI]
|
0.000265783
|
|
|
convulsions, benign familial infantile, 1
|
[NCBI]
|
0.000265783
|
|
|
malignant hyperthermia, susceptibility to, 2
|
[NCBI]
|
0.000265783
|
|
|
electroencephalogram, low-voltage
|
[NCBI]
|
0.000265783
|
|
|
OFC3
|
[NCBI]
|
0.000265783
|
|
|
KLK3
|
[NCBI]
|
0.000257983
|
|
|
EEC1
|
[NCBI]
|
0.000245649
|
|
|
IBD1
|
[NCBI]
|
0.000243029
|
|
|
AVP
|
[NCBI]
|
0.000236335
|
|
|
MKS2
|
[NCBI]
|
0.000231575
|
|
|
hereditary motor and sensory neuropathy v
|
[NCBI]
|
0.000231575
|
|
|
immunoglobulin m, level of
|
[NCBI]
|
0.000231575
|
|
|
stature as a quantitative trait
|
[NCBI]
|
0.000231575
|
|
|
SCZD10
|
[NCBI]
|
0.000231575
|
|
|
OFD4
|
[NCBI]
|
0.000231575
|
|
|
PCNA
|
[NCBI]
|
0.000230743
|
|
|
SHEP2
|
[NCBI]
|
0.000214598
|
|
|
HSCR1
|
[NCBI]
|
0.000214221
|
|
|
GC
|
[NCBI]
|
0.000213813
|
|
|
GFAP
|
[NCBI]
|
0.000213188
|
|
|
NPY
|
[NCBI]
|
0.000211544
|
|
|
HBFQTL2
|
[NCBI]
|
0.000209602
|
|
|
HPA1
|
[NCBI]
|
0.000209491
|
|
|
EPO
|
[NCBI]
|
0.00020744
|
|
|
human immunodeficiency virus type 1, susceptibility to
|
[NCBI]
|
0.000206912
|
|
|
maxillonasal dysplasia, binder type
|
[NCBI]
|
0.000203854
|
|
|
duane retraction syndrome 2
|
[NCBI]
|
0.000203854
|
|
|
BMND3
|
[NCBI]
|
0.000203854
|
|
|
MENOQ1
|
[NCBI]
|
0.000203854
|
|
|
progeroid syndrome, neonatal
|
[NCBI]
|
0.000203854
|
|
|
CFEOM3
|
[NCBI]
|
0.000203854
|
|
|
DA5
|
[NCBI]
|
0.000203854
|
|
|
HBA2
|
[NCBI]
|
0.000199671
|
|
|
EGFR
|
[NCBI]
|
0.000199014
|
|
|
PI
|
[NCBI]
|
0.000198726
|
|
|
BCHE
|
[NCBI]
|
0.000188391
|
|
|
homocystinuria due to deficiency of n(5,10)-methylenetetrahydrofolate reductase activity
|
[NCBI]
|
0.000185994
|
|
|
SCZD
|
[NCBI]
|
0.000182129
|
|
|
gordon syndrome
|
[NCBI]
|
0.000180744
|
|
|
neuroticism
|
[NCBI]
|
0.000180744
|
|
|
short rib-polydactyly syndrome, type iii
|
[NCBI]
|
0.000180744
|
|
|
AUTS9
|
[NCBI]
|
0.000180744
|
|
|
myoclonic epilepsy, juvenile, 3
|
[NCBI]
|
0.000180744
|
|
|
ANON1
|
[NCBI]
|
0.000180744
|
|
|
alzheimer disease 5
|
[NCBI]
|
0.000180744
|
|
|
protocadherin-alpha gene cluster
|
[NCBI]
|
0.000174178
|
|
|
ARMD4
|
[NCBI]
|
0.000174178
|
|
|
acrocephalopolysyndactyly type iv
|
[NCBI]
|
0.000169489
|
|
|
MBL2
|
[NCBI]
|
0.000166602
|
|
|
MDD
|
[NCBI]
|
0.000166133
|
|
|
mycobacterium tuberculosis, susceptibility to
|
[NCBI]
|
0.000163805
|
|
|
SRS
|
[NCBI]
|
0.000162595
|
|
|
ALB
|
[NCBI]
|
0.000161756
|
|
|
SCZD7
|
[NCBI]
|
0.000161083
|
|
|
IGES
|
[NCBI]
|
0.000161083
|
|
|
IBD2
|
[NCBI]
|
0.000161083
|
|
|
mohr syndrome
|
[NCBI]
|
0.000161083
|
|
|
SCZD6
|
[NCBI]
|
0.000161083
|
|
|
NOD2
|
[NCBI]
|
0.000160885
|
|
|
endometrial cancer
|
[NCBI]
|
0.000159662
|
|
|
CA1
|
[NCBI]
|
0.000159123
|
|
|
antithrombin iii deficiency
|
[NCBI]
|
0.000157247
|
|
|
AGT
|
[NCBI]
|
0.000155985
|
|
|
GPI
|
[NCBI]
|
0.000155578
|
|
|
APOE
|
[NCBI]
|
0.000155299
|
|
|
MODY
|
[NCBI]
|
0.000148949
|
|
|
HBD
|
[NCBI]
|
0.000147409
|
|
|
spatial visualization, aptitude for
|
[NCBI]
|
0.000144097
|
|
|
stiff skin syndrome
|
[NCBI]
|
0.000144097
|
|
|
CCK
|
[NCBI]
|
0.000143757
|
|
|
EL1
|
[NCBI]
|
0.000143233
|
|
|
CRH
|
[NCBI]
|
0.000142352
|
|
|
malaria, susceptibility to
|
[NCBI]
|
0.000142317
|
|
|
SPTA1
|
[NCBI]
|
0.000142236
|
|
|
TBG
|
[NCBI]
|
0.00014213
|
|
|
NIDDM1
|
[NCBI]
|
0.00014125
|
|
|
VIP
|
[NCBI]
|
0.000138713
|
|
|
storage pool platelet disease
|
[NCBI]
|
0.00012925
|
|
|
AUTS6
|
[NCBI]
|
0.00012925
|
|
|
dandy-walker-like malformation with atrioventricular septal defect
|
[NCBI]
|
0.00012925
|
|
|
XPV
|
[NCBI]
|
0.000127475
|
|
|
APOA1
|
[NCBI]
|
0.000126738
|
|
|
TH
|
[NCBI]
|
0.000124797
|
|
|
MG
|
[NCBI]
|
0.000122405
|
|
|
asthma, susceptibility to
|
[NCBI]
|
0.000120251
|
|
|
PCOS1
|
[NCBI]
|
0.000117355
|
|
|
osteogenesis imperfecta, type iia
|
[NCBI]
|
0.000117054
|
|
|
acyl-coa dehydrogenase, short-chain, deficiency of
|
[NCBI]
|
0.000116498
|
|
|
WS2A
|
[NCBI]
|
0.000116498
|
|
|
CAT
|
[NCBI]
|
0.000116213
|
|
|
anencephaly
|
[NCBI]
|
0.000116151
|
|
|
ETL2
|
[NCBI]
|
0.000116151
|
|
|
galactosemia
|
[NCBI]
|
0.000115118
|
|
|
roussy-levy hereditary areflexic dystasia
|
[NCBI]
|
0.000114528
|
|
|
EBN2
|
[NCBI]
|
0.000114528
|
|
|
CAPN10
|
[NCBI]
|
0.000114379
|
|
|
IS1
|
[NCBI]
|
0.000114251
|
|
|
ELAC2
|
[NCBI]
|
0.000110749
|
|
|
STL1
|
[NCBI]
|
0.000110658
|
|
|
EIG
|
[NCBI]
|
0.000108087
|
|
|
ACADS
|
[NCBI]
|
0.000106576
|
|
|
PEE1
|
[NCBI]
|
0.000105275
|
|
|
MRD
|
[NCBI]
|
0.000104508
|
|
|
megacystis-microcolon-intestinal hypoperistalsis syndrome
|
[NCBI]
|
0.000104508
|
|
|
CEACAM5
|
[NCBI]
|
0.000104252
|
|
|
vohwinkel syndrome, variant form
|
[NCBI]
|
0.000102952
|
|
|
pseudohypoaldosteronism, type i, autosomal dominant
|
[NCBI]
|
0.000102952
|
|
|
PGM1
|
[NCBI]
|
0.000100279
|
|
|
CRC
|
[NCBI]
|
0.000100135
|
|
|
MAOA
|
[NCBI]
|
9.8463e-05
|
|
|
lactase persistence
|
[NCBI]
|
9.48019e-05
|
|
|
protocadherin-beta gene cluster
|
[NCBI]
|
9.41492e-05
|
|
|
leber optic atrophy, susceptibility to
|
[NCBI]
|
9.40947e-05
|
|
|
CFH
|
[NCBI]
|
9.36132e-05
|
|
|
TSD
|
[NCBI]
|
9.23017e-05
|
|
|
NPPA
|
[NCBI]
|
8.99039e-05
|
|
|
MPO
|
[NCBI]
|
8.97948e-05
|
|
|
CHAT
|
[NCBI]
|
8.87374e-05
|
|
|
IGER
|
[NCBI]
|
8.72935e-05
|
|
|
NEM2
|
[NCBI]
|
8.70538e-05
|
|
|
deafness, congenital, with keratopachydermia and constrictions of fingers and toes
|
[NCBI]
|
8.70538e-05
|
|
|
SHEP3
|
[NCBI]
|
8.70538e-05
|
|
|
pfeiffer syndrome
|
[NCBI]
|
8.69928e-05
|
|
|
ADH2
|
[NCBI]
|
8.65015e-05
|
|
|
fragile x mental retardation syndrome
|
[NCBI]
|
8.64584e-05
|
|
|
DRD4
|
[NCBI]
|
8.58653e-05
|
|
|
HNF1A
|
[NCBI]
|
8.47774e-05
|
|
|
glaucoma-related pigment dispersion syndrome
|
[NCBI]
|
8.47365e-05
|
|
|
DURS1
|
[NCBI]
|
8.47365e-05
|
|
|
gangliosidosis, gm2, juvenile, a(m)b variant
|
[NCBI]
|
8.47353e-05
|
|
|
dent disease 2
|
[NCBI]
|
8.47353e-05
|
|
|
CISS1
|
[NCBI]
|
8.47353e-05
|
|
|
CDLS3
|
[NCBI]
|
8.47353e-05
|
|
|
tented eyebrows
|
[NCBI]
|
8.47353e-05
|
|
|
blood group--public systems
|
[NCBI]
|
8.47353e-05
|
|
|
morquio syndrome, nonkeratosulfate-excreting type
|
[NCBI]
|
8.47353e-05
|
|
|
immotile cilia syndrome due to excessively long cilia
|
[NCBI]
|
8.47353e-05
|
|
|
FSGS3
|
[NCBI]
|
8.47353e-05
|
|
|
cataract, sutural, with punctate and cerulean opacities
|
[NCBI]
|
8.47353e-05
|
|
|
arthrogryposis, distal, type 2e
|
[NCBI]
|
8.47353e-05
|
|
|
DFNB53
|
[NCBI]
|
8.47353e-05
|
|
|
taurodontism
|
[NCBI]
|
8.47353e-05
|
|
|
HBFQTL5
|
[NCBI]
|
8.47353e-05
|
|
|
peroneal nerve, accessory deep
|
[NCBI]
|
8.47353e-05
|
|
|
sclerocornea, autosomal dominant
|
[NCBI]
|
8.47353e-05
|
|
|
charcot-marie-tooth peroneal muscular atrophy and friedreich ataxia, combined
|
[NCBI]
|
8.47353e-05
|
|
|
qt interval, variation in
|
[NCBI]
|
8.47353e-05
|
|
|
fructose utilization
|
[NCBI]
|
8.47353e-05
|
|
|
GCK
|
[NCBI]
|
8.41318e-05
|
|
|
ABCA4
|
[NCBI]
|
8.27951e-05
|
|
|
TF
|
[NCBI]
|
8.18548e-05
|
|
|
prostate cancer/brain cancer susceptibility
|
[NCBI]
|
8.11207e-05
|
|
|
protocadherin-gamma gene cluster
|
[NCBI]
|
8.11207e-05
|
|
|
colorectal adenomatous polyposis, autosomal recessive
|
[NCBI]
|
8.11207e-05
|
|
|
TPMT
|
[NCBI]
|
8.06315e-05
|
|
|
AMY1A
|
[NCBI]
|
7.9439e-05
|
|
|
osteogenesis imperfecta, type i
|
[NCBI]
|
7.85438e-05
|
|
|
ACHE
|
[NCBI]
|
7.81715e-05
|
|
|
HBG2
|
[NCBI]
|
7.66182e-05
|
|
|
MRX1
|
[NCBI]
|
7.62921e-05
|
|
|
hexokinase deficiency hemolytic anemia
|
[NCBI]
|
7.60313e-05
|
|
|
morquio syndrome b
|
[NCBI]
|
7.60313e-05
|
|
|
tobacco addiction, susceptibility to
|
[NCBI]
|
7.60313e-05
|
|
|
TNFSF6
|
[NCBI]
|
7.5184e-05
|
|
|
AFP
|
[NCBI]
|
7.42987e-05
|
|
|
MTCO2
|
[NCBI]
|
7.41472e-05
|
|
|
MHS1
|
[NCBI]
|
7.32791e-05
|
|
|
severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-negative, nk cell-negative, due to adenosine deaminase deficiency
|
[NCBI]
|
7.2116e-05
|
|
|
WS1
|
[NCBI]
|
7.19188e-05
|
|
|
MS
|
[NCBI]
|
7.17741e-05
|
|
|
WZS
|
[NCBI]
|
7.15832e-05
|
|
|
aryl hydrocarbon hydroxylase inducibility
|
[NCBI]
|
7.15832e-05
|
|
|
MCPH5
|
[NCBI]
|
7.15832e-05
|
|
|
alzheimer disease, susceptibility to, mitochondrial
|
[NCBI]
|
7.15832e-05
|
|
|
DA1
|
[NCBI]
|
7.15832e-05
|
|
|
SLC22A1
|
[NCBI]
|
7.14742e-05
|
|
|
RP
|
[NCBI]
|
7.02401e-05
|
|
|
DTNBP1
|
[NCBI]
|
6.92384e-05
|
|
|
F2
|
[NCBI]
|
6.88372e-05
|
|
|
ALDH1A1
|
[NCBI]
|
6.82093e-05
|
|
|
phosphoglycerate kinase 1 deficiency
|
[NCBI]
|
6.76392e-05
|
|
|
MTHFR
|
[NCBI]
|
6.48742e-05
|
|
|
MKS1
|
[NCBI]
|
6.44158e-05
|
|
|
GH2
|
[NCBI]
|
6.24134e-05
|
|
|
TCF7L2
|
[NCBI]
|
6.23512e-05
|
|
|
HGF
|
[NCBI]
|
6.22069e-05
|
|
|
MUTYH
|
[NCBI]
|
6.17787e-05
|
|
|
abdominal obesity-metabolic syndrome
|
[NCBI]
|
6.17073e-05
|
|
|
CDAN2
|
[NCBI]
|
6.17073e-05
|
|
|
costello syndrome
|
[NCBI]
|
6.16511e-05
|
|
|
prostate cancer
|
[NCBI]
|
6.10372e-05
|
|
|
SHEP1
|
[NCBI]
|
6.09002e-05
|
|
|
NIDDM
|
[NCBI]
|
5.99598e-05
|
|
|
CJD
|
[NCBI]
|
5.98682e-05
|
|
|
INSIG2
|
[NCBI]
|
5.96391e-05
|
|
|
PPARG
|
[NCBI]
|
5.92311e-05
|
|
|
GDNF
|
[NCBI]
|
5.85846e-05
|
|
|
drug metabolism, poor, cyp2d6-related
|
[NCBI]
|
5.85351e-05
|
|
|
LPG
|
[NCBI]
|
5.79795e-05
|
|
|
CFEOM1
|
[NCBI]
|
5.79795e-05
|
|
|
IDDM
|
[NCBI]
|
5.76931e-05
|
|
|
GALT
|
[NCBI]
|
5.76783e-05
|
|
|
fibromuscular dysplasia of arteries
|
[NCBI]
|
5.72551e-05
|
|
|
ARMD9
|
[NCBI]
|
5.72551e-05
|
|
|
periodontitis, chronic
|
[NCBI]
|
5.72551e-05
|
|
|
STQTL9
|
[NCBI]
|
5.72551e-05
|
|
|
pseudoacromegaly with severe insulin resistance
|
[NCBI]
|
5.72551e-05
|
|
|
MRD1
|
[NCBI]
|
5.72551e-05
|
|
|
ichthyosis, cyclic, with epidermolytic hyperkeratosis
|
[NCBI]
|
5.72551e-05
|
|
|
SHEP4
|
[NCBI]
|
5.72551e-05
|
|
|
myoclonic epilepsy, progressive
|
[NCBI]
|
5.72551e-05
|
|
|
cataract, autosomal dominant
|
[NCBI]
|
5.72551e-05
|
|
|
CMT2K
|
[NCBI]
|
5.72551e-05
|
|
|
myocardial infarction, susceptibility to, 1
|
[NCBI]
|
5.72551e-05
|
|
|
GLC1G
|
[NCBI]
|
5.72551e-05
|
|
|
stocco dos santos x-linked mental retardation syndrome
|
[NCBI]
|
5.72551e-05
|
|
|
CMH10
|
[NCBI]
|
5.72551e-05
|
|
|
acetaminophen metabolism
|
[NCBI]
|
5.72551e-05
|
|
|
uric acid nephrolithiasis, susceptibility to
|
[NCBI]
|
5.72551e-05
|
|
|
MCOPS5
|
[NCBI]
|
5.72551e-05
|
|
|
median-ulnar nerve communications
|
[NCBI]
|
5.72551e-05
|
|
|
CC
|
[NCBI]
|
5.72551e-05
|
|
|
summitt syndrome
|
[NCBI]
|
5.72551e-05
|
|
|
AME2
|
[NCBI]
|
5.72551e-05
|
|
|
ND
|
[NCBI]
|
5.68631e-05
|
|
|
ZDHHC8
|
[NCBI]
|
5.66112e-05
|
|
|
MBP
|
[NCBI]
|
5.61371e-05
|
|
|
LGMD2B
|
[NCBI]
|
5.52981e-05
|
|
|
PTK2
|
[NCBI]
|
5.48558e-05
|
|
|
transcobalamin ii deficiency
|
[NCBI]
|
5.42861e-05
|
|
|
hypertension, essential
|
[NCBI]
|
5.30238e-05
|
|
|
ADH1
|
[NCBI]
|
5.29528e-05
|
|
|
RAI1
|
[NCBI]
|
5.29528e-05
|
|
|
MSR1
|
[NCBI]
|
5.29528e-05
|
|
|
pseudoxanthoma elasticum, forme fruste
|
[NCBI]
|
5.28227e-05
|
|
|
coumarin resistance
|
[NCBI]
|
5.28227e-05
|
|
|
AFD1
|
[NCBI]
|
5.28227e-05
|
|
|
LDHB
|
[NCBI]
|
5.22971e-05
|
|
|
mucopolysaccharidosis type iva
|
[NCBI]
|
5.18159e-05
|
|
|
PDZD11
|
[NCBI]
|
5.09757e-05
|
|
|
GUK3
|
[NCBI]
|
5.09757e-05
|
|
|
RBKS
|
[NCBI]
|
5.09757e-05
|
|
|
HPC1
|
[NCBI]
|
5.05266e-05
|
|
|
SPG2
|
[NCBI]
|
5.05266e-05
|
|
|
MFS
|
[NCBI]
|
5.05103e-05
|
|
|
small cell cancer of the lung
|
[NCBI]
|
4.96422e-05
|
|
|
ME2
|
[NCBI]
|
4.94198e-05
|
|
|
TGFB1
|
[NCBI]
|
4.93648e-05
|
|
|
GNRH1
|
[NCBI]
|
4.91219e-05
|
|
|
SPTB
|
[NCBI]
|
4.90978e-05
|
|
|
CMM
|
[NCBI]
|
4.871e-05
|
|
|
APOB
|
[NCBI]
|
4.84646e-05
|
|
|
OFD1
|
[NCBI]
|
4.83879e-05
|
|
|
ABS
|
[NCBI]
|
4.83879e-05
|
|
|
GABEB
|
[NCBI]
|
4.83879e-05
|
|
|
TAS2R10
|
[NCBI]
|
4.83561e-05
|
|
|
VMD
|
[NCBI]
|
4.80035e-05
|
|
|
AMY2A
|
[NCBI]
|
4.78499e-05
|
|
|
CCR5
|
[NCBI]
|
4.71866e-05
|
|
|
SMS
|
[NCBI]
|
4.71105e-05
|
|
|
ALPS2A
|
[NCBI]
|
4.70657e-05
|
|
|
osteogenesis imperfecta, type iib
|
[NCBI]
|
4.70657e-05
|
|
|
MRT3
|
[NCBI]
|
4.70657e-05
|
|
|
keratitis, hereditary
|
[NCBI]
|
4.70657e-05
|
|
|
NSIAD
|
[NCBI]
|
4.70657e-05
|
|
|
PEE4
|
[NCBI]
|
4.70657e-05
|
|
|
ARMD10
|
[NCBI]
|
4.70657e-05
|
|
|
MADB
|
[NCBI]
|
4.70657e-05
|
|
|
cafe-au-lait spots, multiple
|
[NCBI]
|
4.70657e-05
|
|
|
polydactyly
|
[NCBI]
|
4.70657e-05
|
|
|
moved to 310600
|
[NCBI]
|
4.70657e-05
|
|
|
diaphragmatic hernia 3
|
[NCBI]
|
4.70657e-05
|
|
|
macular dystrophy, concentric annular
|
[NCBI]
|
4.70657e-05
|
|
|
tuberous sclerosis 4
|
[NCBI]
|
4.70657e-05
|
|
|
microduplication 22q11.2
|
[NCBI]
|
4.70657e-05
|
|
|
isovaleric acid, inability to smell
|
[NCBI]
|
4.70657e-05
|
|
|
sertoli cell-only syndrome
|
[NCBI]
|
4.70657e-05
|
|
|
LDHCP
|
[NCBI]
|
4.70657e-05
|
|
|
thyroid hormonogenesis, genetic defect in, 6
|
[NCBI]
|
4.70657e-05
|
|
|
hypotonia-cystinuria syndrome
|
[NCBI]
|
4.70657e-05
|
|
|
advanced sleep-phase syndrome, familial
|
[NCBI]
|
4.70657e-05
|
|
|
charcot-marie-tooth disease, axonal, type 2e
|
[NCBI]
|
4.70657e-05
|
|
|
osteogenesis imperfecta, type iv
|
[NCBI]
|
4.63886e-05
|
|
|
RNASEL
|
[NCBI]
|
4.63879e-05
|
|
|
HEMB
|
[NCBI]
|
4.63356e-05
|
|
|
TNFRSF11B
|
[NCBI]
|
4.54177e-05
|
|
|
NS1
|
[NCBI]
|
4.54151e-05
|
|
|
TARDBP
|
[NCBI]
|
4.53917e-05
|
|
|
MAFD1
|
[NCBI]
|
4.50897e-05
|
|
|
HBZ
|
[NCBI]
|
4.50206e-05
|
|
|
CYP2D6
|
[NCBI]
|
4.48385e-05
|
|
|
refsum disease, infantile form
|
[NCBI]
|
4.45136e-05
|
|
|
DA2A
|
[NCBI]
|
4.45136e-05
|
|
|
epidermolysis bullosa letalis
|
[NCBI]
|
4.45136e-05
|
|
|
autonomic control, congenital failure of
|
[NCBI]
|
4.45136e-05
|
|
|
IRDN
|
[NCBI]
|
4.37369e-05
|
|
|
FMO3
|
[NCBI]
|
4.37085e-05
|
|
|
ACTN3
|
[NCBI]
|
4.28796e-05
|
|
|
osteogenesis imperfecta, type iii
|
[NCBI]
|
4.275e-05
|
|
|
LCP1
|
[NCBI]
|
4.25277e-05
|
|
|
PGD
|
[NCBI]
|
4.25277e-05
|
|
|
NAT1
|
[NCBI]
|
4.19089e-05
|
|
|
MTR
|
[NCBI]
|
4.1887e-05
|
|
|
HSPCA
|
[NCBI]
|
4.13852e-05
|
|
|
DRD3
|
[NCBI]
|
4.13852e-05
|
|
|
ulcerative colitis, susceptibility to
|
[NCBI]
|
4.1087e-05
|
|
|
aortic aneurysm, abdominal
|
[NCBI]
|
4.1087e-05
|
|
|
PTPRC
|
[NCBI]
|
4.06776e-05
|
|
|
bartter syndrome, antenatal, type 1
|
[NCBI]
|
4.05517e-05
|
|
|
ARMD2
|
[NCBI]
|
4.05517e-05
|
|
|
CMD1G
|
[NCBI]
|
4.05517e-05
|
|
|
carotid intimal medial thickness 1
|
[NCBI]
|
4.05517e-05
|
|
|
retinitis pigmentosa-deafness syndrome
|
[NCBI]
|
4.05517e-05
|
|
|
VAMAS1
|
[NCBI]
|
4.05517e-05
|
|
|
coronary heart disease, susceptibility to, 5
|
[NCBI]
|
4.05517e-05
|
|
|
cyanide, inability to smell
|
[NCBI]
|
4.05517e-05
|
|
|
AIS1
|
[NCBI]
|
4.05517e-05
|
|
|
DI
|
[NCBI]
|
4.05517e-05
|
|
|
EEG
|
[NCBI]
|
4.05517e-05
|
|
|
chylothorax, congenital
|
[NCBI]
|
4.05517e-05
|
|
|
orofacial cleft 5
|
[NCBI]
|
4.05517e-05
|
|
|
SPG7
|
[NCBI]
|
4.05517e-05
|
|
|
asthma-related traits, susceptibility to, 2
|
[NCBI]
|
4.05517e-05
|
|
|
buruli ulcer, susceptibility to
|
[NCBI]
|
4.05517e-05
|
|
|
cardiac arrhythmia, ankyrin-b-related
|
[NCBI]
|
4.05517e-05
|
|
|
spondyloperipheral dysplasia
|
[NCBI]
|
4.05517e-05
|
|
|
isobutyryl-coa dehydrogenase deficiency
|
[NCBI]
|
4.05517e-05
|
|
|
clubfoot
|
[NCBI]
|
4.05517e-05
|
|
|
lactase deficiency, congenital
|
[NCBI]
|
4.05517e-05
|
|
|
simpson-golabi-behmel syndrome, type 2
|
[NCBI]
|
4.05517e-05
|
|
|
osteogenesis imperfecta, type vii
|
[NCBI]
|
4.05517e-05
|
|
|
PGK1
|
[NCBI]
|
4.02918e-05
|
|
|
SLC11A1
|
[NCBI]
|
4.02918e-05
|
|
|
PWS
|
[NCBI]
|
4.00697e-05
|
|
|
C4B
|
[NCBI]
|
3.99761e-05
|
|
|
nebulette
|
[NCBI]
|
3.96977e-05
|
|
|
PPP3CC
|
[NCBI]
|
3.96977e-05
|
|
|
diaphragmatic hernia, congenital
|
[NCBI]
|
3.96039e-05
|
|
|
CLN1
|
[NCBI]
|
3.95152e-05
|
|
|
MADA
|
[NCBI]
|
3.95152e-05
|
|
|
FY
|
[NCBI]
|
3.92948e-05
|
|
|
CASP8
|
[NCBI]
|
3.92752e-05
|
|
|
RHD
|
[NCBI]
|
3.92752e-05
|
|
|
MDH1
|
[NCBI]
|
3.87798e-05
|
|
|
HSR
|
[NCBI]
|
3.82971e-05
|
|
|
LHB
|
[NCBI]
|
3.82971e-05
|
|
|
IRS1
|
[NCBI]
|
3.82783e-05
|
|
|
acyl-coa dehydrogenase, medium-chain, deficiency of
|
[NCBI]
|
3.80264e-05
|
|
|
INS
|
[NCBI]
|
3.72492e-05
|
|
|
COMT
|
[NCBI]
|
3.71464e-05
|
|
|
MCM6
|
[NCBI]
|
3.70624e-05
|
|
|
ITPA
|
[NCBI]
|
3.70624e-05
|
|
|
ADH3
|
[NCBI]
|
3.70624e-05
|
|
|
loc387715 gene
|
[NCBI]
|
3.70624e-05
|
|
|
MS4A2
|
[NCBI]
|
3.70624e-05
|
|
|
thiourea tasting
|
[NCBI]
|
3.66136e-05
|
|
|
CACNA1C
|
[NCBI]
|
3.64732e-05
|
|
|
NPC1
|
[NCBI]
|
3.62528e-05
|
|
|
NEM1
|
[NCBI]
|
3.57833e-05
|
|
|
carpenter syndrome
|
[NCBI]
|
3.57833e-05
|
|
|
STL3
|
[NCBI]
|
3.57833e-05
|
|
|
paroxysmal extreme pain disorder
|
[NCBI]
|
3.57833e-05
|
|
|
dentinogenesis imperfecta, shields type iii
|
[NCBI]
|
3.57833e-05
|
|
|
granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type ii
|
[NCBI]
|
3.57833e-05
|
|
|
JAE
|
[NCBI]
|
3.57833e-05
|
|
|
spinal muscular atrophy, type i, with congenital bone fractures
|
[NCBI]
|
3.57833e-05
|
|
|
DFNA13
|
[NCBI]
|
3.57833e-05
|
|
|
EBDSC
|
[NCBI]
|
3.57833e-05
|
|
|
trismus-pseudocamptodactyly syndrome
|
[NCBI]
|
3.57833e-05
|
|
|
osteogenesis imperfecta, type viii
|
[NCBI]
|
3.57833e-05
|
|
|
PAX3
|
[NCBI]
|
3.55236e-05
|
|
|
KIR3DL1
|
[NCBI]
|
3.55111e-05
|
|
|
LEPR
|
[NCBI]
|
3.52143e-05
|
|
|
von willebrand disease
|
[NCBI]
|
3.52028e-05
|
|
|
PLG
|
[NCBI]
|
3.48556e-05
|
|
|
F3
|
[NCBI]
|
3.46682e-05
|
|
|
KRN1
|
[NCBI]
|
3.46456e-05
|
|
|
TRPC4
|
[NCBI]
|
3.46456e-05
|
|
|
TRMI1
|
[NCBI]
|
3.46456e-05
|
|
|
PCDHA4
|
[NCBI]
|
3.46456e-05
|
|
|
TPH2
|
[NCBI]
|
3.40975e-05
|
|
|
FABP2
|
[NCBI]
|
3.40186e-05
|
|
|
HBFQTL1
|
[NCBI]
|
3.39917e-05
|
|
|
FHM1
|
[NCBI]
|
3.39917e-05
|
|
|
mucopolysaccharidosis type vii
|
[NCBI]
|
3.39917e-05
|
|
|
LMNA
|
[NCBI]
|
3.38521e-05
|
|
|
IDE
|
[NCBI]
|
3.3522e-05
|
|
|
FGA
|
[NCBI]
|
3.34373e-05
|
|
|
isoniazid inactivation
|
[NCBI]
|
3.28866e-05
|
|
|
POLH
|
[NCBI]
|
3.28003e-05
|
|
|
HBG1
|
[NCBI]
|
3.26498e-05
|
|
|
APOH
|
[NCBI]
|
3.25392e-05
|
|
|
CF
|
[NCBI]
|
3.22707e-05
|
|
|
sarcosinemia
|
[NCBI]
|
3.20429e-05
|
|
|
noonan-like/multiple giant cell lesion syndrome
|
[NCBI]
|
3.20429e-05
|
|
|
CCM2
|
[NCBI]
|
3.20429e-05
|
|
|
polydactyly, preaxial iv
|
[NCBI]
|
3.20429e-05
|
|
|
USH2C
|
[NCBI]
|
3.20429e-05
|
|
|
MRT1
|
[NCBI]
|
3.20429e-05
|
|
|
HOMG2
|
[NCBI]
|
3.20429e-05
|
|
|
gaucher disease, atypical, due to saposin c deficiency
|
[NCBI]
|
3.20429e-05
|
|
|
naxos disease
|
[NCBI]
|
3.20429e-05
|
|
|
thyroxine-binding globulin of serum
|
[NCBI]
|
3.20429e-05
|
|
|
HCA2
|
[NCBI]
|
3.20429e-05
|
|
|
goldberg-shprintzen megacolon syndrome
|
[NCBI]
|
3.20429e-05
|
|
|
STGD1
|
[NCBI]
|
3.16079e-05
|
|
|
granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type i
|
[NCBI]
|
3.16079e-05
|
|
|
alzheimer disease 3
|
[NCBI]
|
3.16079e-05
|
|
|
GPHN
|
[NCBI]
|
3.16025e-05
|
|
|
FOXP2
|
[NCBI]
|
3.16025e-05
|
|
|
SPP1
|
[NCBI]
|
3.14002e-05
|
|
|
GYPE
|
[NCBI]
|
3.12033e-05
|
|
|
GDF9
|
[NCBI]
|
3.12033e-05
|
|
|
ENPP1
|
[NCBI]
|
3.11663e-05
|
|
|
HLA-B
|
[NCBI]
|
3.11663e-05
|
|
|
MN
|
[NCBI]
|
3.11663e-05
|
|
|
gaucher disease, type i
|
[NCBI]
|
3.09144e-05
|
|
|
PXE
|
[NCBI]
|
3.08113e-05
|
|
|
TFPI
|
[NCBI]
|
3.07257e-05
|
|
|
RP3
|
[NCBI]
|
3.04948e-05
|
|
|
PLIN
|
[NCBI]
|
3.04907e-05
|
|
|
BEST1
|
[NCBI]
|
3.04907e-05
|
|
|
FTD
|
[NCBI]
|
2.96172e-05
|
|
|
GNB3
|
[NCBI]
|
2.94541e-05
|
|
|
CLN6
|
[NCBI]
|
2.89819e-05
|
|
|
KNO
|
[NCBI]
|
2.89819e-05
|
|
|
body mass index
|
[NCBI]
|
2.89819e-05
|
|
|
short stature, idiopathic, autosomal
|
[NCBI]
|
2.89819e-05
|
|
|
gaucher disease, type iiic
|
[NCBI]
|
2.89819e-05
|
|
|
methylcobalamin deficiency, cblg type
|
[NCBI]
|
2.89819e-05
|
|
|
CCM3
|
[NCBI]
|
2.89819e-05
|
|
|
STL2
|
[NCBI]
|
2.89819e-05
|
|
|
CORD3
|
[NCBI]
|
2.89819e-05
|
|
|
EAD
|
[NCBI]
|
2.89819e-05
|
|
|
ehlers-danlos syndrome, progeroid form
|
[NCBI]
|
2.89819e-05
|
|
|
floating-harbor syndrome
|
[NCBI]
|
2.89819e-05
|
|
|
chromosome 16p13.3 deletion syndrome
|
[NCBI]
|
2.89819e-05
|
|
|
ARMD7
|
[NCBI]
|
2.89819e-05
|
|
|
hypercholesterolemia, autosomal dominant
|
[NCBI]
|
2.86869e-05
|
|
|
DLG5
|
[NCBI]
|
2.85847e-05
|
|
|
FUCA2
|
[NCBI]
|
2.85847e-05
|
|
|
MTTH
|
[NCBI]
|
2.85847e-05
|
|
|
HK3
|
[NCBI]
|
2.85847e-05
|
|
|
TCRD
|
[NCBI]
|
2.84837e-05
|
|
|
NOS3
|
[NCBI]
|
2.83336e-05
|
|
|
CVID
|
[NCBI]
|
2.8245e-05
|
|
|
ESR2
|
[NCBI]
|
2.812e-05
|
|
|
CYP3A4
|
[NCBI]
|
2.812e-05
|
|
|
ALDH2
|
[NCBI]
|
2.812e-05
|
|
|
HEXA
|
[NCBI]
|
2.77666e-05
|
|
|
AOS
|
[NCBI]
|
2.75823e-05
|
|
|
migraine with or without aura, susceptibility to, 1
|
[NCBI]
|
2.75823e-05
|
|
|
ADRB3
|
[NCBI]
|
2.75721e-05
|
|
|
OPTN
|
[NCBI]
|
2.75673e-05
|
|
|
SHH
|
[NCBI]
|
2.72908e-05
|
|
|
GHR
|
[NCBI]
|
2.72731e-05
|
|
|
BRCA1
|
[NCBI]
|
2.71076e-05
|
|
|
PDYN
|
[NCBI]
|
2.70311e-05
|
|
|
AGTR1
|
[NCBI]
|
2.70311e-05
|
|
|
myoclonic dystonia
|
[NCBI]
|
2.64899e-05
|
|
|
SP110
|
[NCBI]
|
2.64731e-05
|
|
|
TLR10
|
[NCBI]
|
2.64731e-05
|
|
|
GRM5
|
[NCBI]
|
2.64731e-05
|
|
|
SLC6A9
|
[NCBI]
|
2.64731e-05
|
|
|
PPARGC1B
|
[NCBI]
|
2.64731e-05
|
|
|
MGEA5
|
[NCBI]
|
2.64731e-05
|
|
|
PPP1R3A
|
[NCBI]
|
2.64731e-05
|
|
|
IL23R
|
[NCBI]
|
2.64731e-05
|
|
|
de sanctis-cacchione syndrome
|
[NCBI]
|
2.64038e-05
|
|
|
psoriatic arthritis, susceptibility to
|
[NCBI]
|
2.64038e-05
|
|
|
kuru, susceptibility to
|
[NCBI]
|
2.64038e-05
|
|
|
IDD
|
[NCBI]
|
2.64038e-05
|
|
|
vitiligo
|
[NCBI]
|
2.64038e-05
|
|
|
pseudo-von willebrand disease
|
[NCBI]
|
2.64038e-05
|
|
|
SCA8
|
[NCBI]
|
2.64038e-05
|
|
|
AITD3
|
[NCBI]
|
2.64038e-05
|
|
|
IBM3
|
[NCBI]
|
2.64038e-05
|
|
|
VMCM
|
[NCBI]
|
2.64038e-05
|
|
|
mal de meleda
|
[NCBI]
|
2.64038e-05
|
|
|
cryptorchidism, unilateral or bilateral
|
[NCBI]
|
2.64038e-05
|
|
|
hypertriglyceridemia, familial
|
[NCBI]
|
2.64038e-05
|
|
|
FGFR2
|
[NCBI]
|
2.59966e-05
|
|
|
ALPP
|
[NCBI]
|
2.59014e-05
|
|
|
ORM1
|
[NCBI]
|
2.59014e-05
|
|
|
TBS
|
[NCBI]
|
2.55869e-05
|
|
|
PCTT
|
[NCBI]
|
2.55869e-05
|
|
|
RNPEPL1
|
[NCBI]
|
2.5487e-05
|
|
|
PCDHB2
|
[NCBI]
|
2.5487e-05
|
|
|
PCDHGB5
|
[NCBI]
|
2.5487e-05
|
|
|
PCDHGB3
|
[NCBI]
|
2.5487e-05
|
|
|
PCDHGA9
|
[NCBI]
|
2.5487e-05
|
|
|
OR7D4
|
[NCBI]
|
2.5487e-05
|
|
|
asthma-associated alternatively spliced gene 1
|
[NCBI]
|
2.5487e-05
|
|
|
PCDHGC5
|
[NCBI]
|
2.5487e-05
|
|
|
PDK3
|
[NCBI]
|
2.5487e-05
|
|
|
otospiralin
|
[NCBI]
|
2.5487e-05
|
|
|
PCDHGA2
|
[NCBI]
|
2.5487e-05
|
|
|
prpk-binding protein
|
[NCBI]
|
2.5487e-05
|
|
|
HLA-DOB
|
[NCBI]
|
2.5487e-05
|
|
|
lymphocyte cytosol polypeptide, 40-kd
|
[NCBI]
|
2.5487e-05
|
|
|
PCDHGA4
|
[NCBI]
|
2.5487e-05
|
|
|
PCDHB7
|
[NCBI]
|
2.5487e-05
|
|
|
PCDHB4
|
[NCBI]
|
2.5487e-05
|
|
|
PCDHGB6
|
[NCBI]
|
2.5487e-05
|
|
|
PDK1
|
[NCBI]
|
2.5487e-05
|
|
|
TBC1D3G
|
[NCBI]
|
2.5487e-05
|
|
|
GLYCTK
|
[NCBI]
|
2.5487e-05
|
|
|
PCDHB15
|
[NCBI]
|
2.5487e-05
|
|
|
PCDHB3
|
[NCBI]
|
2.5487e-05
|
|
|
PCDHB8
|
[NCBI]
|
2.5487e-05
|
|
|
NUDT7
|
[NCBI]
|
2.5487e-05
|
|
|
lymphocyte cytosol polypeptide, 49-kd
|
[NCBI]
|
2.5487e-05
|
|
|
PCDHGA10
|
[NCBI]
|
2.5487e-05
|
|
|
RNASE6
|
[NCBI]
|
2.5487e-05
|
|
|
TBC1D3D
|
[NCBI]
|
2.5487e-05
|
|
|
PCDHB14
|
[NCBI]
|
2.5487e-05
|
|
|
PCDHGA1
|
[NCBI]
|
2.5487e-05
|
|
|
PCDHB5
|
[NCBI]
|
2.5487e-05
|
|
|
ESA5
|
[NCBI]
|
2.5487e-05
|
|
|
PCDHGA6
|
[NCBI]
|
2.5487e-05
|
|
|
PDK2
|
[NCBI]
|
2.5487e-05
|
|
|
OR1F1
|
[NCBI]
|
2.5487e-05
|
|
|
PCDHB12
|
[NCBI]
|
2.5487e-05
|
|
|
monophosphoglycerate mutase
|
[NCBI]
|
2.5487e-05
|
|
|
TBC1D3C
|
[NCBI]
|
2.5487e-05
|
|
|
methionine aminopeptidase 1d
|
[NCBI]
|
2.5487e-05
|
|
|
BMND8
|
[NCBI]
|
2.5487e-05
|
|
|
PCDHGA11
|
[NCBI]
|
2.5487e-05
|
|
|
TBC1D3H
|
[NCBI]
|
2.5487e-05
|
|
|
TGM7
|
[NCBI]
|
2.5487e-05
|
|
|
TBC1D3F
|
[NCBI]
|
2.5487e-05
|
|
|
C2ORF34
|
[NCBI]
|
2.5487e-05
|
|
|
PCDHB13
|
[NCBI]
|
2.5487e-05
|
|
|
CCNB2
|
[NCBI]
|
2.5487e-05
|
|
|
PCDHB1
|
[NCBI]
|
2.5487e-05
|
|
|
PCDHGA7
|
[NCBI]
|
2.5487e-05
|
|
|
PCDHGB2
|
[NCBI]
|
2.5487e-05
|
|
|
PCDHGB1
|
[NCBI]
|
2.5487e-05
|
|
|
MTMR14
|
[NCBI]
|
2.5487e-05
|
|
|
H2AFB
|
[NCBI]
|
2.5487e-05
|
|
|
PVT1
|
[NCBI]
|
2.5487e-05
|
|
|
TBC1D3E
|
[NCBI]
|
2.5487e-05
|
|
|
HIST1H2BA
|
[NCBI]
|
2.5487e-05
|
|
|
MIAT
|
[NCBI]
|
2.5487e-05
|
|
|
CD
|
[NCBI]
|
2.53147e-05
|
|
|
RET
|
[NCBI]
|
2.5209e-05
|
|
|
OR1D2
|
[NCBI]
|
2.51324e-05
|
|
|
vitamin d-dependent rickets, type ii
|
[NCBI]
|
2.47187e-05
|
|
|
ACP2
|
[NCBI]
|
2.47067e-05
|
|
|
CCHCR1
|
[NCBI]
|
2.47067e-05
|
|
|
USP9Y
|
[NCBI]
|
2.47067e-05
|
|
|
TMC1
|
[NCBI]
|
2.47067e-05
|
|
|
SLC22A4
|
[NCBI]
|
2.47067e-05
|
|
|
lynch syndrome i
|
[NCBI]
|
2.4653e-05
|
|
|
SCA2
|
[NCBI]
|
2.4653e-05
|
|
|
arbitrary restriction polymorphism 1
|
[NCBI]
|
2.41866e-05
|
|
|
por deficiency
|
[NCBI]
|
2.41866e-05
|
|
|
HFE3
|
[NCBI]
|
2.41866e-05
|
|
|
immunoosseous dysplasia, schimke type
|
[NCBI]
|
2.41866e-05
|
|
|
granulomatous disease, chronic, autosomal recessive, cytochrome b-negative
|
[NCBI]
|
2.41866e-05
|
|
|
CMT4B2
|
[NCBI]
|
2.41866e-05
|
|
|
ehlers-danlos syndrome, type vii, autosomal dominant
|
[NCBI]
|
2.41866e-05
|
|
|
OPTA2
|
[NCBI]
|
2.41866e-05
|
|
|
macular dystrophy, vitelliform, adult-onset
|
[NCBI]
|
2.41866e-05
|
|
|
polydactyly, postaxial, type a1
|
[NCBI]
|
2.41866e-05
|
|
|
ADHR
|
[NCBI]
|
2.41866e-05
|
|
|
dyskeratosis congenita, autosomal dominant
|
[NCBI]
|
2.41866e-05
|
|
|
emanuel syndrome
|
[NCBI]
|
2.41866e-05
|
|
|
corticosteroid-binding globulin deficiency
|
[NCBI]
|
2.41866e-05
|
|
|
lymphoma, non-hodgkin, familial
|
[NCBI]
|
2.41269e-05
|
|
|
nijmegen breakage syndrome
|
[NCBI]
|
2.38832e-05
|
|
|
MTND3
|
[NCBI]
|
2.37076e-05
|
|
|
VLDLR
|
[NCBI]
|
2.36773e-05
|
|
|
methemoglobinemia due to deficiency of methemoglobin reductase
|
[NCBI]
|
2.32478e-05
|
|
|
FGF7
|
[NCBI]
|
2.26945e-05
|
|
|
PSORS1
|
[NCBI]
|
2.25094e-05
|
|
|
NRG1
|
[NCBI]
|
2.24948e-05
|
|
|
COL3A1
|
[NCBI]
|
2.24205e-05
|
|
|
GLO1
|
[NCBI]
|
2.2413e-05
|
|
|
PGP
|
[NCBI]
|
2.2413e-05
|
|
|
LYZ
|
[NCBI]
|
2.2413e-05
|
|
|
HTR2A
|
[NCBI]
|
2.2413e-05
|
|
|
RNASE3
|
[NCBI]
|
2.23905e-05
|
|
|
hematopoietic stem cell kinetics, control of
|
[NCBI]
|
2.22497e-05
|
|
|
renal tubular acidosis, distal, with progressive nerve deafness
|
[NCBI]
|
2.22497e-05
|
|
|
CSNB2A
|
[NCBI]
|
2.22497e-05
|
|
|
CZP1
|
[NCBI]
|
2.22497e-05
|
|
|
DFNB9
|
[NCBI]
|
2.22497e-05
|
|
|
erythermalgia, primary
|
[NCBI]
|
2.22497e-05
|
|
|
alport syndrome, autosomal recessive
|
[NCBI]
|
2.22497e-05
|
|
|
SPG17
|
[NCBI]
|
2.22497e-05
|
|
|
hepatitis b virus, susceptibility to
|
[NCBI]
|
2.22497e-05
|
|
|
HBE1
|
[NCBI]
|
2.18653e-05
|
|
|
HTRA1
|
[NCBI]
|
2.18653e-05
|
|
|
APOA5
|
[NCBI]
|
2.18653e-05
|
|
|
LRP8
|
[NCBI]
|
2.18083e-05
|
|
|
GSTM1
|
[NCBI]
|
2.18083e-05
|
|
|
PF4
|
[NCBI]
|
2.17108e-05
|
|
|
COL1A1
|
[NCBI]
|
2.08499e-05
|
|
|
CDSP
|
[NCBI]
|
2.08348e-05
|
|
|
PEPC
|
[NCBI]
|
2.06895e-05
|
|
|
GMPR
|
[NCBI]
|
2.06895e-05
|
|
|
ALPI
|
[NCBI]
|
2.06895e-05
|
|
|
ST8SIA4
|
[NCBI]
|
2.06895e-05
|
|
|
CCL4
|
[NCBI]
|
2.06895e-05
|
|
|
LAMC1
|
[NCBI]
|
2.06895e-05
|
|
|
HK2
|
[NCBI]
|
2.06895e-05
|
|
|
metachromatic leukodystrophy due to saposin b deficiency
|
[NCBI]
|
2.05367e-05
|
|
|
galactokinase deficiency
|
[NCBI]
|
2.05367e-05
|
|
|
uridine 5-prime monophosphate hydrolase deficiency, hemolytic anemia due to
|
[NCBI]
|
2.05367e-05
|
|
|
MCOPS3
|
[NCBI]
|
2.05367e-05
|
|
|
PHA1
|
[NCBI]
|
2.05367e-05
|
|
|
CMT2A2
|
[NCBI]
|
2.05367e-05
|
|
|
BDA1
|
[NCBI]
|
2.05367e-05
|
|
|
GVM
|
[NCBI]
|
2.05367e-05
|
|
|
SCZD2
|
[NCBI]
|
2.05367e-05
|
|
|
coloboma, ocular
|
[NCBI]
|
2.05367e-05
|
|
|
marshall syndrome
|
[NCBI]
|
2.05367e-05
|
|
|
AS
|
[NCBI]
|
2.00492e-05
|
|
|
LCT
|
[NCBI]
|
1.984e-05
|
|
|
LEP
|
[NCBI]
|
1.98386e-05
|
|
|
C3
|
[NCBI]
|
1.9819e-05
|
|
|
MCPH1
|
[NCBI]
|
1.96346e-05
|
|
|
ASPM
|
[NCBI]
|
1.96346e-05
|
|
|
IRF5
|
[NCBI]
|
1.96346e-05
|
|
|
IRS2
|
[NCBI]
|
1.9627e-05
|
|
|
DRD2
|
[NCBI]
|
1.94801e-05
|
|
|
XPA
|
[NCBI]
|
1.94667e-05
|
|
|
neuraminidase deficiency with beta-galactosidase deficiency
|
[NCBI]
|
1.91333e-05
|
|
|
von willebrand disease, recessive form
|
[NCBI]
|
1.90066e-05
|
|
|
encephalopathy, neonatal severe, due to mecp2 mutations
|
[NCBI]
|
1.90066e-05
|
|
|
SMA4
|
[NCBI]
|
1.90066e-05
|
|
|
sertoli cell-only syndrome, y-linked
|
[NCBI]
|
1.90066e-05
|
|
|
CLN5
|
[NCBI]
|
1.90066e-05
|
|
|
apolipoprotein c-ii deficiency
|
[NCBI]
|
1.90066e-05
|
|
|
amyloidosis, primary cutaneous
|
[NCBI]
|
1.90066e-05
|
|
|
sarcoidosis
|
[NCBI]
|
1.90066e-05
|
|
|
IHPS1
|
[NCBI]
|
1.90066e-05
|
|
|
DA2B
|
[NCBI]
|
1.90066e-05
|
|
|
CMT2B
|
[NCBI]
|
1.90066e-05
|
|
|
spermatogenic failure, nonobstructive, y-linked
|
[NCBI]
|
1.88173e-05
|
|
|
ESD
|
[NCBI]
|
1.87226e-05
|
|
|
diphosphoglycerate mutase deficiency of erythrocyte
|
[NCBI]
|
1.86792e-05
|
|
|
TERC
|
[NCBI]
|
1.86576e-05
|
|
|
oca2 gene
|
[NCBI]
|
1.86576e-05
|
|
|
CFTR
|
[NCBI]
|
1.85368e-05
|
|
|
CDKN2A
|
[NCBI]
|
1.85229e-05
|
|
|
MMP9
|
[NCBI]
|
1.85066e-05
|
|
|
PSEN1
|
[NCBI]
|
1.82664e-05
|
|
|
DYT1
|
[NCBI]
|
1.81895e-05
|
|
|
SCS
|
[NCBI]
|
1.81895e-05
|
|
|
PYY
|
[NCBI]
|
1.80524e-05
|
|
|
HCRTR2
|
[NCBI]
|
1.78073e-05
|
|
|
HLA-C
|
[NCBI]
|
1.78073e-05
|
|
|
GOT1
|
[NCBI]
|
1.78073e-05
|
|
|
PEPA
|
[NCBI]
|
1.78073e-05
|
|
|
CYP3A5
|
[NCBI]
|
1.78073e-05
|
|
|
DRD1
|
[NCBI]
|
1.78073e-05
|
|
|
GAL
|
[NCBI]
|
1.77646e-05
|
|
|
GSN
|
[NCBI]
|
1.77561e-05
|
|
|
complement component 2 deficiency
|
[NCBI]
|
1.77561e-05
|
|
|
RARA
|
[NCBI]
|
1.77561e-05
|
|
|
CBD
|
[NCBI]
|
1.77561e-05
|
|
|
PRNP
|
[NCBI]
|
1.7669e-05
|
|
|
multiple pterygium syndrome, lethal type
|
[NCBI]
|
1.76289e-05
|
|
|
BMND1
|
[NCBI]
|
1.76289e-05
|
|
|
OPPG
|
[NCBI]
|
1.76289e-05
|
|
|
multiple pterygium syndrome, escobar variant
|
[NCBI]
|
1.76289e-05
|
|
|
bartter syndrome, antenatal, type 2
|
[NCBI]
|
1.76289e-05
|
|
|
crouzon syndrome
|
[NCBI]
|
1.76289e-05
|
|
|
synovitis, granulomatous, with uveitis and cranial neuropathies
|
[NCBI]
|
1.76289e-05
|
|
|
parkinson disease, mitochondrial
|
[NCBI]
|
1.76289e-05
|
|
|
EPHX1
|
[NCBI]
|
1.73284e-05
|
|
|
IL13
|
[NCBI]
|
1.73284e-05
|
|
|
GHRL
|
[NCBI]
|
1.73284e-05
|
|
|
PCDHAC2
|
[NCBI]
|
1.7322e-05
|
|
|
OR13G1
|
[NCBI]
|
1.7322e-05
|
|
|
PCDHB10
|
[NCBI]
|
1.7322e-05
|
|
|
DACH2
|
[NCBI]
|
1.7322e-05
|
|
|
DHRS4
|
[NCBI]
|
1.7322e-05
|
|
|
RPIA
|
[NCBI]
|
1.7322e-05
|
|
|
PCDHGA8
|
[NCBI]
|
1.7322e-05
|
|
|
CHRFAM7A
|
[NCBI]
|
1.7322e-05
|
|
|
SIGLECL1
|
[NCBI]
|
1.7322e-05
|
|
|
C6ORF15
|
[NCBI]
|
1.7322e-05
|
|
|
DOM3Z
|
[NCBI]
|
1.7322e-05
|
|
|
LRCH1
|
[NCBI]
|
1.7322e-05
|
|
|
SPDEF
|
[NCBI]
|
1.7322e-05
|
|
|
minisatellite 33.6
|
[NCBI]
|
1.7322e-05
|
|
|
PCDHA12
|
[NCBI]
|
1.7322e-05
|
|
|
KLF14
|
[NCBI]
|
1.7322e-05
|
|
|
TBC1D3B
|
[NCBI]
|
1.7322e-05
|
|
|
HIST2H2AC
|
[NCBI]
|
1.7322e-05
|
|
|
minisatellite 33.15
|
[NCBI]
|
1.7322e-05
|
|
|
PCDHGA5
|
[NCBI]
|
1.7322e-05
|
|
|
PCDHAC1
|
[NCBI]
|
1.7322e-05
|
|
|
PCDHB11
|
[NCBI]
|
1.7322e-05
|
|
|
PGA3
|
[NCBI]
|
1.7322e-05
|
|
|
KIF21A
|
[NCBI]
|
1.7322e-05
|
|
|
KCNQ5
|
[NCBI]
|
1.7322e-05
|
|
|
PCDHGB7
|
[NCBI]
|
1.7322e-05
|
|
|
CPXM
|
[NCBI]
|
1.7322e-05
|
|
|
PCDHA1
|
[NCBI]
|
1.7322e-05
|
|
|
breast cancer cell 2
|
[NCBI]
|
1.7322e-05
|
|
|
MATN4
|
[NCBI]
|
1.7322e-05
|
|
|
MTNR1B
|
[NCBI]
|
1.7322e-05
|
|
|
PCDHGB4
|
[NCBI]
|
1.7322e-05
|
|
|
SLC22A17
|
[NCBI]
|
1.7322e-05
|
|
|
COX7A2L
|
[NCBI]
|
1.7322e-05
|
|
|
CBR3
|
[NCBI]
|
1.7322e-05
|
|
|
KCNG2
|
[NCBI]
|
1.7322e-05
|
|
|
PCDHB9
|
[NCBI]
|
1.7322e-05
|
|
|
BBS7
|
[NCBI]
|
1.7322e-05
|
|
|
TAS2R50
|
[NCBI]
|
1.7322e-05
|
|
|
KIAA1109
|
[NCBI]
|
1.7322e-05
|
|
|
PCDHA5
|
[NCBI]
|
1.7322e-05
|
|
|
pin2-interacting protein 1
|
[NCBI]
|
1.7322e-05
|
|
|
TBC1D3
|
[NCBI]
|
1.7322e-05
|
|
|
PCDHA6
|
[NCBI]
|
1.7322e-05
|
|
|
TBL2
|
[NCBI]
|
1.7322e-05
|
|
|
PCDHGC4
|
[NCBI]
|
1.7322e-05
|
|
|
RGS18
|
[NCBI]
|
1.7322e-05
|
|
|
TTLL6
|
[NCBI]
|
1.7322e-05
|
|
|
PCDHB6
|
[NCBI]
|
1.7322e-05
|
|
|
PCDHA13
|
[NCBI]
|
1.7322e-05
|
|
|
SLC2A11
|
[NCBI]
|
1.7322e-05
|
|
|
ARHGAP10
|
[NCBI]
|
1.7322e-05
|
|
|
PCDHGA3
|
[NCBI]
|
1.7322e-05
|
|
|
PCDHA3
|
[NCBI]
|
1.7322e-05
|
|
|
phosphoglycerate mutase family 3
|
[NCBI]
|
1.7322e-05
|
|
|
GTF3C1
|
[NCBI]
|
1.7322e-05
|
|
|
GPR35
|
[NCBI]
|
1.7322e-05
|
|
|
GFPT2
|
[NCBI]
|
1.7322e-05
|
|
|
MBD5
|
[NCBI]
|
1.7322e-05
|
|
|
UGT1A1
|
[NCBI]
|
1.73004e-05
|
|
|
BL
|
[NCBI]
|
1.7133e-05
|
|
|
APOC3
|
[NCBI]
|
1.70064e-05
|
|
|
RNR1
|
[NCBI]
|
1.70064e-05
|
|
|
AGTR2
|
[NCBI]
|
1.70064e-05
|
|
|
ACP1
|
[NCBI]
|
1.69148e-05
|
|
|
DDC
|
[NCBI]
|
1.6821e-05
|
|
|
APP
|
[NCBI]
|
1.6662e-05
|
|
|
ZS
|
[NCBI]
|
1.66566e-05
|
|
|
GH1
|
[NCBI]
|
1.65318e-05
|
|
|
APOC2
|
[NCBI]
|
1.65147e-05
|
|
|
FGG
|
[NCBI]
|
1.65147e-05
|
|
|
GPT
|
[NCBI]
|
1.64575e-05
|
|
|
glioma of brain, familial
|
[NCBI]
|
1.64271e-05
|
|
|
LNS
|
[NCBI]
|
1.64271e-05
|
|
|
MODY1
|
[NCBI]
|
1.638e-05
|
|
|
ISS
|
[NCBI]
|
1.638e-05
|
|
|
anemia, dyserythropoietic congenital, type i
|
[NCBI]
|
1.638e-05
|
|
|
NFNS
|
[NCBI]
|
1.638e-05
|
|
|
FRA16A
|
[NCBI]
|
1.638e-05
|
|
|
WGN1
|
[NCBI]
|
1.638e-05
|
|
|
gm1-gangliosidosis, type iii
|
[NCBI]
|
1.638e-05
|
|
|
erythrocytosis, familial, 2
|
[NCBI]
|
1.638e-05
|
|
|
niemann-pick disease, type b
|
[NCBI]
|
1.638e-05
|
|
|
mucolipidosis iiia
|
[NCBI]
|
1.638e-05
|
|
|
LGMD2I
|
[NCBI]
|
1.638e-05
|
|
|
JME
|
[NCBI]
|
1.638e-05
|
|
|
PPS
|
[NCBI]
|
1.638e-05
|
|
|
tetralogy of fallot
|
[NCBI]
|
1.638e-05
|
|
|
HMN5
|
[NCBI]
|
1.638e-05
|
|
|
disorganization, mouse, homolog of
|
[NCBI]
|
1.638e-05
|
|
|
alpers diffuse degeneration of cerebral gray matter with hepatic cirrhosis
|
[NCBI]
|
1.638e-05
|
|
|
KCNQ2
|
[NCBI]
|
1.62667e-05
|
|
|
ALOX5AP
|
[NCBI]
|
1.62667e-05
|
|
|
PKHD1
|
[NCBI]
|
1.62667e-05
|
|
|
SSTR5
|
[NCBI]
|
1.62667e-05
|
|
|
CHEK2
|
[NCBI]
|
1.61273e-05
|
|
|
NF1
|
[NCBI]
|
1.60854e-05
|
|
|
holoprosencephaly
|
[NCBI]
|
1.59503e-05
|
|
|
HHT
|
[NCBI]
|
1.5877e-05
|
|
|
PKLR
|
[NCBI]
|
1.57519e-05
|
|
|
ANG
|
[NCBI]
|
1.56624e-05
|
|
|
phenylketonuria
|
[NCBI]
|
1.56373e-05
|
|
|
CRYBB2
|
[NCBI]
|
1.55803e-05
|
|
|
PCSK1
|
[NCBI]
|
1.55803e-05
|
|
|
SCARB1
|
[NCBI]
|
1.55803e-05
|
|
|
NCF1
|
[NCBI]
|
1.55803e-05
|
|
|
MC3R
|
[NCBI]
|
1.55803e-05
|
|
|
IRF6
|
[NCBI]
|
1.55803e-05
|
|
|
COL5A1
|
[NCBI]
|
1.55803e-05
|
|
|
SCN9A
|
[NCBI]
|
1.55803e-05
|
|
|
ADIPOR1
|
[NCBI]
|
1.55803e-05
|
|
|
AR
|
[NCBI]
|
1.55277e-05
|
|
|
CNTF
|
[NCBI]
|
1.5478e-05
|
|
|
EDN1
|
[NCBI]
|
1.53881e-05
|
|
|
maple syrup urine disease
|
[NCBI]
|
1.53443e-05
|
|
|
HHF2
|
[NCBI]
|
1.53443e-05
|
|
|
nondisjunction
|
[NCBI]
|
1.52415e-05
|
|
|
dent disease 1
|
[NCBI]
|
1.52415e-05
|
|
|
mowat-wilson syndrome
|
[NCBI]
|
1.52415e-05
|
|
|
PALS
|
[NCBI]
|
1.52415e-05
|
|
|
holocarboxylase synthetase deficiency
|
[NCBI]
|
1.52415e-05
|
|
|
complement factor h deficiency
|
[NCBI]
|
1.52415e-05
|
|
|
MC4R
|
[NCBI]
|
1.51569e-05
|
|
|
CTGF
|
[NCBI]
|
1.51528e-05
|
|
|
FFI
|
[NCBI]
|
1.51438e-05
|
|
|
MYOC
|
[NCBI]
|
1.51062e-05
|
|
|
KEL
|
[NCBI]
|
1.49406e-05
|
|
|
USH2A
|
[NCBI]
|
1.49406e-05
|
|
|
FGB
|
[NCBI]
|
1.49406e-05
|
|
|
OSM
|
[NCBI]
|
1.47293e-05
|
|
|
RTT
|
[NCBI]
|
1.46636e-05
|
|
|
STAT3
|
[NCBI]
|
1.45964e-05
|
|
|
VDR
|
[NCBI]
|
1.44376e-05
|
|
|
SCA1
|
[NCBI]
|
1.44312e-05
|
|
|
ADIPOQ
|
[NCBI]
|
1.43598e-05
|
|
|
IL6R
|
[NCBI]
|
1.43423e-05
|
|
|
BHMT
|
[NCBI]
|
1.43423e-05
|
|
|
NEFL
|
[NCBI]
|
1.43423e-05
|
|
|
ACY1
|
[NCBI]
|
1.43423e-05
|
|
|
Ge
|
[NCBI]
|
1.43423e-05
|
|
|
ERBB2IP
|
[NCBI]
|
1.42915e-05
|
|
|
HS1BP3
|
[NCBI]
|
1.42915e-05
|
|
|
ST3GAL6
|
[NCBI]
|
1.42915e-05
|
|
|
STOX1
|
[NCBI]
|
1.42915e-05
|
|
|
CACNG5
|
[NCBI]
|
1.42915e-05
|
|
|
lymphocyte cytosol polypeptide, 20-kd
|
[NCBI]
|
1.42915e-05
|
|
|
SLC7A6
|
[NCBI]
|
1.42915e-05
|
|
|
PCDHA8
|
[NCBI]
|
1.42915e-05
|
|
|
PDLIM4
|
[NCBI]
|
1.42915e-05
|
|
|
KIR3DL3
|
[NCBI]
|
1.42915e-05
|
|
|
AS3MT
|
[NCBI]
|
1.42915e-05
|
|
|
PPM1B
|
[NCBI]
|
1.42915e-05
|
|
|
MTTA
|
[NCBI]
|
1.42915e-05
|
|
|
PCDHA10
|
[NCBI]
|
1.42915e-05
|
|
|
PCDHGA12
|
[NCBI]
|
1.42915e-05
|
|
|
ADH6
|
[NCBI]
|
1.42915e-05
|
|
|
SMARCAL1
|
[NCBI]
|
1.42915e-05
|
|
|
SIGLEC8
|
[NCBI]
|
1.42915e-05
|
|
|
ZNF200
|
[NCBI]
|
1.42915e-05
|
|
|
ANXA13
|
[NCBI]
|
1.42915e-05
|
|
|
ANGPT4
|
[NCBI]
|
1.42915e-05
|
|
|
PCDHA7
|
[NCBI]
|
1.42915e-05
|
|
|
PLS3
|
[NCBI]
|
1.42915e-05
|
|
|
NOS1AP
|
[NCBI]
|
1.42915e-05
|
|
|
ZNF365
|
[NCBI]
|
1.42915e-05
|
|
|
LOXL3
|
[NCBI]
|
1.42915e-05
|
|
|
CRBN
|
[NCBI]
|
1.42915e-05
|
|
|
PCDHA11
|
[NCBI]
|
1.42915e-05
|
|
|
CACNG3
|
[NCBI]
|
1.42915e-05
|
|
|
ANXA11
|
[NCBI]
|
1.42915e-05
|
|
|
PCDHA2
|
[NCBI]
|
1.42915e-05
|
|
|
P2RX5
|
[NCBI]
|
1.42915e-05
|
|
|
PCDHB16
|
[NCBI]
|
1.42915e-05
|
|
|
TAF7
|
[NCBI]
|
1.42915e-05
|
|
|
SLC24A5
|
[NCBI]
|
1.42915e-05
|
|
|
AKAP10
|
[NCBI]
|
1.42915e-05
|
|
|
GPR109A
|
[NCBI]
|
1.42915e-05
|
|
|
actin-binding protein, 34-kd
|
[NCBI]
|
1.42915e-05
|
|
|
SACP
|
[NCBI]
|
1.42915e-05
|
|
|
GRM3
|
[NCBI]
|
1.42915e-05
|
|
|
CA10
|
[NCBI]
|
1.42915e-05
|
|
|
SIGLEC10
|
[NCBI]
|
1.42915e-05
|
|
|
HHLA1
|
[NCBI]
|
1.42915e-05
|
|
|
USP26
|
[NCBI]
|
1.42915e-05
|
|
|
MUC3B
|
[NCBI]
|
1.42915e-05
|
|
|
MS4A5
|
[NCBI]
|
1.42915e-05
|
|
|
LZTS1
|
[NCBI]
|
1.42915e-05
|
|
|
HLA-DO
|
[NCBI]
|
1.42915e-05
|
|
|
TP53RK
|
[NCBI]
|
1.42915e-05
|
|
|
ABCG4
|
[NCBI]
|
1.42915e-05
|
|
|
WDR36
|
[NCBI]
|
1.42915e-05
|
|
|
TXNRD3
|
[NCBI]
|
1.42915e-05
|
|
|
TOX3
|
[NCBI]
|
1.42915e-05
|
|
|
MTTS2
|
[NCBI]
|
1.42915e-05
|
|
|
ABCC12
|
[NCBI]
|
1.42915e-05
|
|
|
MTRNR2
|
[NCBI]
|
1.42915e-05
|
|
|
helicobacter pylori infection, susceptibility to
|
[NCBI]
|
1.41986e-05
|
|
|
PFIC1
|
[NCBI]
|
1.41986e-05
|
|
|
CMDD
|
[NCBI]
|
1.41986e-05
|
|
|
hurler-scheie syndrome
|
[NCBI]
|
1.41986e-05
|
|
|
alexander disease
|
[NCBI]
|
1.41986e-05
|
|
|
IVA
|
[NCBI]
|
1.41986e-05
|
|
|
FBN1
|
[NCBI]
|
1.41662e-05
|
|
|
G6PT1
|
[NCBI]
|
1.3781e-05
|
|
|
FOXL2
|
[NCBI]
|
1.3781e-05
|
|
|
XRCC9
|
[NCBI]
|
1.3781e-05
|
|
|
C4A
|
[NCBI]
|
1.37223e-05
|
|
|
RASA1
|
[NCBI]
|
1.36708e-05
|
|
|
TYMS
|
[NCBI]
|
1.34196e-05
|
|
|
tay-sachs disease, ab variant
|
[NCBI]
|
1.32527e-05
|
|
|
CA2
|
[NCBI]
|
1.32527e-05
|
|
|
GALK1
|
[NCBI]
|
1.32527e-05
|
|
|
DMBT1
|
[NCBI]
|
1.32527e-05
|
|
|
MKKS
|
[NCBI]
|
1.32394e-05
|
|
|
refsum disease
|
[NCBI]
|
1.32394e-05
|
|
|
diabetes-deafness syndrome, maternally transmitted
|
[NCBI]
|
1.32394e-05
|
|
|
longevity
|
[NCBI]
|
1.32394e-05
|
|
|
DHRD
|
[NCBI]
|
1.32394e-05
|
|
|
blood group, p system
|
[NCBI]
|
1.32394e-05
|
|
|
thyroid hormonogenesis, genetic defect in, 2a
|
[NCBI]
|
1.32394e-05
|
|
|
SPCH1
|
[NCBI]
|
1.32394e-05
|
|
|
mucopolysaccharidosis type iiia
|
[NCBI]
|
1.32394e-05
|
|
|
TMAU
|
[NCBI]
|
1.32394e-05
|
|
|
OPTB3
|
[NCBI]
|
1.32394e-05
|
|
|
hyperlipoproteinemia, type i
|
[NCBI]
|
1.32394e-05
|
|
|
periodontitis, aggressive, 1
|
[NCBI]
|
1.32394e-05
|
|
|
NPHS1
|
[NCBI]
|
1.32394e-05
|
|
|
neuropathy, congenital hypomyelinating
|
[NCBI]
|
1.32394e-05
|
|
|
crigler-najjar syndrome
|
[NCBI]
|
1.32394e-05
|
|
|
FMF
|
[NCBI]
|
1.31172e-05
|
|
|
ESR1
|
[NCBI]
|
1.31155e-05
|
|
|
BDNF
|
[NCBI]
|
1.30997e-05
|
|
|
OPMD
|
[NCBI]
|
1.30873e-05
|
|
|
ALPS
|
[NCBI]
|
1.30873e-05
|
|
|
SLS
|
[NCBI]
|
1.29188e-05
|
|
|
HPRT1
|
[NCBI]
|
1.27826e-05
|
|
|
ATM
|
[NCBI]
|
1.27826e-05
|
|
|
PTGS1
|
[NCBI]
|
1.27542e-05
|
|
|
HLA-G
|
[NCBI]
|
1.27542e-05
|
|
|
PKD1
|
[NCBI]
|
1.26192e-05
|
|
|
MSTN
|
[NCBI]
|
1.25481e-05
|
|
|
BPES
|
[NCBI]
|
1.24772e-05
|
|
|
BWS
|
[NCBI]
|
1.23954e-05
|
|
|
SRF
|
[NCBI]
|
1.23604e-05
|
|
|
camurati-engelmann disease
|
[NCBI]
|
1.2354e-05
|
|
|
glycogen storage disease iv
|
[NCBI]
|
1.2354e-05
|
|
|
MNS
|
[NCBI]
|
1.2354e-05
|
|
|
FHM2
|
[NCBI]
|
1.2354e-05
|
|
|
pituitary dwarfism i
|
[NCBI]
|
1.2354e-05
|
|
|
CFHR5
|
[NCBI]
|
1.23525e-05
|
|
|
HDAC10
|
[NCBI]
|
1.23525e-05
|
|
|
PF4V1
|
[NCBI]
|
1.23525e-05
|
|
|
ACTG2
|
[NCBI]
|
1.23525e-05
|
|
|
HCCS
|
[NCBI]
|
1.23525e-05
|
|
|
ADCY6
|
[NCBI]
|
1.23525e-05
|
|
|
SLC6A14
|
[NCBI]
|
1.23525e-05
|
|
|
PHLDA1
|
[NCBI]
|
1.23525e-05
|
|
|
ZNF202
|
[NCBI]
|
1.23525e-05
|
|
|
EFHC1
|
[NCBI]
|
1.23525e-05
|
|
|
OSR2
|
[NCBI]
|
1.23525e-05
|
|
|
RPS4Y
|
[NCBI]
|
1.23525e-05
|
|
|
TRNP3
|
[NCBI]
|
1.23525e-05
|
|
|
CNN1
|
[NCBI]
|
1.23525e-05
|
|
|
MUC7
|
[NCBI]
|
1.23525e-05
|
|
|
CTDP1
|
[NCBI]
|
1.23525e-05
|
|
|
ATP6V1B2
|
[NCBI]
|
1.23525e-05
|
|
|
PDE8A
|
[NCBI]
|
1.23525e-05
|
|
|
solute carrier family 26 (anion transporter), member 6: slc26a6
|
[NCBI]
|
1.23525e-05
|
|
|
SLC28A3
|
[NCBI]
|
1.23525e-05
|
|
|
NPC1L1
|
[NCBI]
|
1.23525e-05
|
|
|
GAPDHS
|
[NCBI]
|
1.23525e-05
|
|
|
KIR2DL5
|
[NCBI]
|
1.23525e-05
|
|
|
MINPP1
|
[NCBI]
|
1.23525e-05
|
|
|
NUCB2
|
[NCBI]
|
1.23525e-05
|
|
|
SSTR4
|
[NCBI]
|
1.23525e-05
|
|
|
NFIB
|
[NCBI]
|
1.23525e-05
|
|
|
FUT9
|
[NCBI]
|
1.23525e-05
|
|
|
POU3F3
|
[NCBI]
|
1.23525e-05
|
|
|
PIK3CB
|
[NCBI]
|
1.23525e-05
|
|
|
hemoglobin--alpha locus 3
|
[NCBI]
|
1.23525e-05
|
|
|
PRKACG
|
[NCBI]
|
1.23525e-05
|
|
|
PRB4
|
[NCBI]
|
1.23525e-05
|
|
|
CHGB
|
[NCBI]
|
1.23525e-05
|
|
|
ACTN2
|
[NCBI]
|
1.23525e-05
|
|
|
ADCY4
|
[NCBI]
|
1.23525e-05
|
|
|
CD109
|
[NCBI]
|
1.23525e-05
|
|
|
CHST1
|
[NCBI]
|
1.23525e-05
|
|
|
RASSF5
|
[NCBI]
|
1.23525e-05
|
|
|
NEF3
|
[NCBI]
|
1.23525e-05
|
|
|
CACNG4
|
[NCBI]
|
1.23525e-05
|
|
|
OCLN
|
[NCBI]
|
1.23525e-05
|
|
|
RFX4
|
[NCBI]
|
1.23525e-05
|
|
|
PREPL
|
[NCBI]
|
1.23525e-05
|
|
|
PCDHGC3
|
[NCBI]
|
1.23525e-05
|
|
|
ASIP
|
[NCBI]
|
1.22829e-05
|
|
|
CYCS
|
[NCBI]
|
1.22829e-05
|
|
|
DGS
|
[NCBI]
|
1.22739e-05
|
|
|
RP2
|
[NCBI]
|
1.22736e-05
|
|
|
AD
|
[NCBI]
|
1.21227e-05
|
|
|
LQT1
|
[NCBI]
|
1.20488e-05
|
|
|
MUC1
|
[NCBI]
|
1.18703e-05
|
|
|
PLAT
|
[NCBI]
|
1.18362e-05
|
|
|
NR3C2
|
[NCBI]
|
1.18362e-05
|
|
|
CYP1B1
|
[NCBI]
|
1.18362e-05
|
|
|
CFB
|
[NCBI]
|
1.17453e-05
|
|
|
SCN5A
|
[NCBI]
|
1.17453e-05
|
|
|
MTND1
|
[NCBI]
|
1.17453e-05
|
|
|
WAS
|
[NCBI]
|
1.16633e-05
|
|
|
HOS
|
[NCBI]
|
1.16332e-05
|
|
|
PCLD
|
[NCBI]
|
1.15342e-05
|
|
|
acyl-coa dehydrogenase, very long-chain, deficiency of
|
[NCBI]
|
1.15342e-05
|
|
|
CBAVD
|
[NCBI]
|
1.15342e-05
|
|
|
ESCS
|
[NCBI]
|
1.15342e-05
|
|
|
EDA
|
[NCBI]
|
1.1412e-05
|
|
|
CYP11B1
|
[NCBI]
|
1.1412e-05
|
|
|
GBA
|
[NCBI]
|
1.13313e-05
|
|
|
HP
|
[NCBI]
|
1.12965e-05
|
|
|
LHCGR
|
[NCBI]
|
1.12429e-05
|
|
|
PROCR
|
[NCBI]
|
1.12429e-05
|
|
|
COL1A2
|
[NCBI]
|
1.11508e-05
|
|
|
POMC
|
[NCBI]
|
1.10859e-05
|
|
|
ACE
|
[NCBI]
|
1.10148e-05
|
|
|
SRD5A2
|
[NCBI]
|
1.10086e-05
|
|
|
SLC3A1
|
[NCBI]
|
1.10086e-05
|
|
|
HLA-DRB1
|
[NCBI]
|
1.10086e-05
|
|
|
NKX2E
|
[NCBI]
|
1.10086e-05
|
|
|
CA9
|
[NCBI]
|
1.09319e-05
|
|
|
LILRA2
|
[NCBI]
|
1.09319e-05
|
|
|
SLC14A2
|
[NCBI]
|
1.09319e-05
|
|
|
IL10RA
|
[NCBI]
|
1.09319e-05
|
|
|
GPR44
|
[NCBI]
|
1.09319e-05
|
|
|
AARS
|
[NCBI]
|
1.09319e-05
|
|
|
membrane-associated protein 17
|
[NCBI]
|
1.09319e-05
|
|
|
OPTC
|
[NCBI]
|
1.09319e-05
|
|
|
NR2C2
|
[NCBI]
|
1.09319e-05
|
|
|
A1BG
|
[NCBI]
|
1.09319e-05
|
|
|
ITGA3
|
[NCBI]
|
1.09319e-05
|
|
|
ABCC11
|
[NCBI]
|
1.09319e-05
|
|
|
HIST2H2BE
|
[NCBI]
|
1.09319e-05
|
|
|
g30 gene
|
[NCBI]
|
1.09319e-05
|
|
|
TGM5
|
[NCBI]
|
1.09319e-05
|
|
|
OC90
|
[NCBI]
|
1.09319e-05
|
|
|
TSTA3
|
[NCBI]
|
1.09319e-05
|
|
|
TRIM5
|
[NCBI]
|
1.09319e-05
|
|
|
FOXD3
|
[NCBI]
|
1.09319e-05
|
|
|
NPY2R
|
[NCBI]
|
1.09319e-05
|
|
|
LAMA4
|
[NCBI]
|
1.09319e-05
|
|
|
SSTR3
|
[NCBI]
|
1.09319e-05
|
|
|
GPD1
|
[NCBI]
|
1.09319e-05
|
|
|
PCDHA9
|
[NCBI]
|
1.09319e-05
|
|
|
ADCY2
|
[NCBI]
|
1.09319e-05
|
|
|
PRKAR1B
|
[NCBI]
|
1.09319e-05
|
|
|
RPE
|
[NCBI]
|
1.09319e-05
|
|
|
ADH7
|
[NCBI]
|
1.09319e-05
|
|
|
PLXNA2
|
[NCBI]
|
1.09319e-05
|
|
|
GABRA6
|
[NCBI]
|
1.09319e-05
|
|
|
NCR3
|
[NCBI]
|
1.09319e-05
|
|
|
PRSS2
|
[NCBI]
|
1.09319e-05
|
|
|
CLN6
|
[NCBI]
|
1.09319e-05
|
|
|
GPR109B
|
[NCBI]
|
1.09319e-05
|
|
|
EFEMP1
|
[NCBI]
|
1.09319e-05
|
|
|
ADCY5
|
[NCBI]
|
1.09319e-05
|
|
|
NPR1
|
[NCBI]
|
1.09319e-05
|
|
|
ZAR1
|
[NCBI]
|
1.09319e-05
|
|
|
NLRP1
|
[NCBI]
|
1.09319e-05
|
|
|
GFRA3
|
[NCBI]
|
1.09319e-05
|
|
|
SNAP23
|
[NCBI]
|
1.09319e-05
|
|
|
SEL1L
|
[NCBI]
|
1.09319e-05
|
|
|
LPL
|
[NCBI]
|
1.08223e-05
|
|
|
mucopolysaccharidosis type iiib
|
[NCBI]
|
1.07731e-05
|
|
|
PARK8
|
[NCBI]
|
1.07731e-05
|
|
|
HEPOD
|
[NCBI]
|
1.07731e-05
|
|
|
severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-negative, nk cell-positive
|
[NCBI]
|
1.07731e-05
|
|
|
BRCA2
|
[NCBI]
|
1.0668e-05
|
|
|
SCN1A
|
[NCBI]
|
1.06242e-05
|
|
|
MTM1
|
[NCBI]
|
1.06242e-05
|
|
|
REN
|
[NCBI]
|
1.0534e-05
|
|
|
GNRHR
|
[NCBI]
|
1.0534e-05
|
|
|
SLOS
|
[NCBI]
|
1.03476e-05
|
|
|
IGF2
|
[NCBI]
|
1.03087e-05
|
|
|
CEL
|
[NCBI]
|
1.03087e-05
|
|
|
IL4R
|
[NCBI]
|
1.02575e-05
|
|
|
GZMA
|
[NCBI]
|
1.02575e-05
|
|
|
SLC22A5
|
[NCBI]
|
1.02575e-05
|
|
|
ATXN8OS
|
[NCBI]
|
1.02575e-05
|
|
|
HGPS
|
[NCBI]
|
1.009e-05
|
|
|
SVAS
|
[NCBI]
|
1.009e-05
|
|
|
porphyria variegata
|
[NCBI]
|
1.009e-05
|
|
|
cutis laxa, x-linked
|
[NCBI]
|
1.00647e-05
|
|
|
MNGIE
|
[NCBI]
|
1.00647e-05
|
|
|
RIEG1
|
[NCBI]
|
1.00647e-05
|
|
|
ETM1
|
[NCBI]
|
1.00647e-05
|
|
|
GPX1
|
[NCBI]
|
9.90718e-06
|
|
|
DYT1
|
[NCBI]
|
9.90718e-06
|
|
|
KL
|
[NCBI]
|
9.90718e-06
|
|
|
CDH1
|
[NCBI]
|
9.87371e-06
|
|
|
SLC2A10
|
[NCBI]
|
9.81652e-06
|
|
|
GFRA2
|
[NCBI]
|
9.81652e-06
|
|
|
ITIH4
|
[NCBI]
|
9.81652e-06
|
|
|
GDA
|
[NCBI]
|
9.81652e-06
|
|
|
VSX1
|
[NCBI]
|
9.81652e-06
|
|
|
SYN2
|
[NCBI]
|
9.81652e-06
|
|
|
CHRNB4
|
[NCBI]
|
9.81652e-06
|
|
|
CKAP2
|
[NCBI]
|
9.81652e-06
|
|
|
GABRA2
|
[NCBI]
|
9.81652e-06
|
|
|
COPA
|
[NCBI]
|
9.81652e-06
|
|
|
NPHP3
|
[NCBI]
|
9.81652e-06
|
|
|
CHE2
|
[NCBI]
|
9.81652e-06
|
|
|
COH1
|
[NCBI]
|
9.81652e-06
|
|
|
SELPLG
|
[NCBI]
|
9.81652e-06
|
|
|
CES2
|
[NCBI]
|
9.81652e-06
|
|
|
ALPPL2
|
[NCBI]
|
9.81652e-06
|
|
|
SLC22A3
|
[NCBI]
|
9.81652e-06
|
|
|
MGP
|
[NCBI]
|
9.81652e-06
|
|
|
IMPA1
|
[NCBI]
|
9.81652e-06
|
|
|
PDLIM7
|
[NCBI]
|
9.81652e-06
|
|
|
GABRA4
|
[NCBI]
|
9.81652e-06
|
|
|
FMO4
|
[NCBI]
|
9.81652e-06
|
|
|
KCNE2
|
[NCBI]
|
9.81652e-06
|
|
|
ALG6
|
[NCBI]
|
9.81652e-06
|
|
|
ANK2
|
[NCBI]
|
9.81652e-06
|
|
|
GPRK2L
|
[NCBI]
|
9.81652e-06
|
|
|
MLX
|
[NCBI]
|
9.81652e-06
|
|
|
DLC1
|
[NCBI]
|
9.81652e-06
|
|
|
KLK8
|
[NCBI]
|
9.81652e-06
|
|
|
SBF2
|
[NCBI]
|
9.81652e-06
|
|
|
BTNL2
|
[NCBI]
|
9.81652e-06
|
|
|
CA5A
|
[NCBI]
|
9.81652e-06
|
|
|
SYNJ1
|
[NCBI]
|
9.81652e-06
|
|
|
VAV3
|
[NCBI]
|
9.81652e-06
|
|
|
SEPS1
|
[NCBI]
|
9.81652e-06
|
|
|
BACE2
|
[NCBI]
|
9.81652e-06
|
|
|
MYL2
|
[NCBI]
|
9.81652e-06
|
|
|
PTPRE
|
[NCBI]
|
9.81652e-06
|
|
|
CDY1
|
[NCBI]
|
9.81652e-06
|
|
|
CALU
|
[NCBI]
|
9.81652e-06
|
|
|
HSPA1L
|
[NCBI]
|
9.81652e-06
|
|
|
HELLS
|
[NCBI]
|
9.81652e-06
|
|
|
H2AFZ
|
[NCBI]
|
9.81652e-06
|
|
|
KIR2DL2
|
[NCBI]
|
9.81652e-06
|
|
|
DDO
|
[NCBI]
|
9.81652e-06
|
|
|
ATP6V1B1
|
[NCBI]
|
9.81652e-06
|
|
|
MSMB
|
[NCBI]
|
9.81652e-06
|
|
|
IMPA2
|
[NCBI]
|
9.81652e-06
|
|
|
g72 gene
|
[NCBI]
|
9.81652e-06
|
|
|
BBS1
|
[NCBI]
|
9.81652e-06
|
|
|
CRMP1
|
[NCBI]
|
9.81652e-06
|
|
|
HNF4A
|
[NCBI]
|
9.66362e-06
|
|
|
TCRB
|
[NCBI]
|
9.57204e-06
|
|
|
HLA-DQA1
|
[NCBI]
|
9.57204e-06
|
|
|
HMGA2
|
[NCBI]
|
9.57204e-06
|
|
|
ITGB3
|
[NCBI]
|
9.45824e-06
|
|
|
mucopolysaccharidosis type vi
|
[NCBI]
|
9.40415e-06
|
|
|
cardiofaciocutaneous syndrome
|
[NCBI]
|
9.40415e-06
|
|
|
sialuria, finnish type
|
[NCBI]
|
9.40415e-06
|
|
|
ehlers-danlos syndrome, type i
|
[NCBI]
|
9.40415e-06
|
|
|
fraser syndrome
|
[NCBI]
|
9.40415e-06
|
|
|
epidermolysis bullosa with pyloric atresia
|
[NCBI]
|
9.40415e-06
|
|
|
CHGA
|
[NCBI]
|
9.25107e-06
|
|
|
PON1
|
[NCBI]
|
9.11599e-06
|
|
|
ADH5
|
[NCBI]
|
8.94335e-06
|
|
|
NPC1
|
[NCBI]
|
8.94335e-06
|
|
|
KCNJ11
|
[NCBI]
|
8.94335e-06
|
|
|
MSH6
|
[NCBI]
|
8.94335e-06
|
|
|
TWIST1
|
[NCBI]
|
8.94335e-06
|
|
|
SMC3
|
[NCBI]
|
8.9029e-06
|
|
|
PDE4B
|
[NCBI]
|
8.9029e-06
|
|
|
CCL7
|
[NCBI]
|
8.9029e-06
|
|
|
PTPRZ1
|
[NCBI]
|
8.9029e-06
|
|
|
PRB2
|
[NCBI]
|
8.9029e-06
|
|
|
PCK1
|
[NCBI]
|
8.9029e-06
|
|
|
SORL1
|
[NCBI]
|
8.9029e-06
|
|
|
RIPK3
|
[NCBI]
|
8.9029e-06
|
|
|
P2RY12
|
[NCBI]
|
8.9029e-06
|
|
|
PDLIM3
|
[NCBI]
|
8.9029e-06
|
|
|
KCNQ3
|
[NCBI]
|
8.9029e-06
|
|
|
ADCY3
|
[NCBI]
|
8.9029e-06
|
|
|
MADD
|
[NCBI]
|
8.9029e-06
|
|
|
FTO
|
[NCBI]
|
8.9029e-06
|
|
|
XCE
|
[NCBI]
|
8.9029e-06
|
|
|
BRD2
|
[NCBI]
|
8.9029e-06
|
|
|
IL13RA1
|
[NCBI]
|
8.9029e-06
|
|
|
BCL11A
|
[NCBI]
|
8.9029e-06
|
|
|
MDH2
|
[NCBI]
|
8.9029e-06
|
|
|
RBMX
|
[NCBI]
|
8.9029e-06
|
|
|
CDKN2D
|
[NCBI]
|
8.9029e-06
|
|
|
SGNE1
|
[NCBI]
|
8.9029e-06
|
|
|
NHLH1
|
[NCBI]
|
8.9029e-06
|
|
|
MPP1
|
[NCBI]
|
8.9029e-06
|
|
|
QKI
|
[NCBI]
|
8.9029e-06
|
|
|
SPAG11
|
[NCBI]
|
8.9029e-06
|
|
|
ADIPOR2
|
[NCBI]
|
8.9029e-06
|
|
|
LST1
|
[NCBI]
|
8.9029e-06
|
|
|
KCND3
|
[NCBI]
|
8.9029e-06
|
|
|
ADH4
|
[NCBI]
|
8.9029e-06
|
|
|
NHLRC1
|
[NCBI]
|
8.9029e-06
|
|
|
SUMO4
|
[NCBI]
|
8.9029e-06
|
|
|
HMGCS2
|
[NCBI]
|
8.9029e-06
|
|
|
PALLD
|
[NCBI]
|
8.9029e-06
|
|
|
HAGH
|
[NCBI]
|
8.9029e-06
|
|
|
TAP2
|
[NCBI]
|
8.9029e-06
|
|
|
ACVR1B
|
[NCBI]
|
8.9029e-06
|
|
|
AMH
|
[NCBI]
|
8.89639e-06
|
|
|
BIRC1
|
[NCBI]
|
8.86898e-06
|
|
|
MLC
|
[NCBI]
|
8.78698e-06
|
|
|
EKV
|
[NCBI]
|
8.78698e-06
|
|
|
CSNB1A
|
[NCBI]
|
8.78698e-06
|
|
|
glycogen storage disease iii
|
[NCBI]
|
8.78698e-06
|
|
|
DRD
|
[NCBI]
|
8.78698e-06
|
|
|
TGD
|
[NCBI]
|
8.78698e-06
|
|
|
PSNP1
|
[NCBI]
|
8.78698e-06
|
|
|
myasthenic syndrome, congenital, associated with acetylcholine receptor deficiency
|
[NCBI]
|
8.78698e-06
|
|
|
sudden infant death syndrome
|
[NCBI]
|
8.78698e-06
|
|
|
USH2A
|
[NCBI]
|
8.78698e-06
|
|
|
niemann-pick disease, type a
|
[NCBI]
|
8.78698e-06
|
|
|
ALDH3A2
|
[NCBI]
|
8.64802e-06
|
|
|
MEFV
|
[NCBI]
|
8.64802e-06
|
|
|
glycogen storage disease ii
|
[NCBI]
|
8.40156e-06
|
|
|
hypogonadotropic hypogonadism
|
[NCBI]
|
8.40156e-06
|
|
|
IL8
|
[NCBI]
|
8.36434e-06
|
|
|
CXCL12
|
[NCBI]
|
8.36434e-06
|
|
|
CMM2
|
[NCBI]
|
8.20945e-06
|
|
|
RMD
|
[NCBI]
|
8.20945e-06
|
|
|
LIP
|
[NCBI]
|
8.20945e-06
|
|
|
hyperglycerolemia
|
[NCBI]
|
8.20945e-06
|
|
|
alcohol dependence
|
[NCBI]
|
8.20945e-06
|
|
|
osteoporosis
|
[NCBI]
|
8.20945e-06
|
|
|
BBS
|
[NCBI]
|
8.1887e-06
|
|
|
CDK5
|
[NCBI]
|
8.16818e-06
|
|
|
hemophagocytic lymphohistiocytosis, familial, 1
|
[NCBI]
|
8.1349e-06
|
|
|
ABCG5
|
[NCBI]
|
8.13266e-06
|
|
|
PDE10A
|
[NCBI]
|
8.13266e-06
|
|
|
ADCYAP1R1
|
[NCBI]
|
8.13266e-06
|
|
|
HADHB
|
[NCBI]
|
8.13266e-06
|
|
|
ROS1
|
[NCBI]
|
8.13266e-06
|
|
|
S100A7
|
[NCBI]
|
8.13266e-06
|
|
|
CAMK2G
|
[NCBI]
|
8.13266e-06
|
|
|
IL8RA
|
[NCBI]
|
8.13266e-06
|
|
|
HNRPA1
|
[NCBI]
|
8.13266e-06
|
|
|
CTF1
|
[NCBI]
|
8.13266e-06
|
|
|
HSD17B1
|
[NCBI]
|
8.13266e-06
|
|
|
PDE5A
|
[NCBI]
|
8.13266e-06
|
|
|
ADCY8
|
[NCBI]
|
8.13266e-06
|
|
|
ATP2A3
|
[NCBI]
|
8.13266e-06
|
|
|
GLRA2
|
[NCBI]
|
8.13266e-06
|
|
|
TRIP10
|
[NCBI]
|
8.13266e-06
|
|
|
AKAP9
|
[NCBI]
|
8.13266e-06
|
|
|
CYP4A11
|
[NCBI]
|
8.13266e-06
|
|
|
AURKC
|
[NCBI]
|
8.13266e-06
|
|
|
IRGM
|
[NCBI]
|
8.13266e-06
|
|
|
AVPR1A
|
[NCBI]
|
8.13266e-06
|
|
|
OPRK1
|
[NCBI]
|
8.13266e-06
|
|
|
EPB72
|
[NCBI]
|
8.13266e-06
|
|
|
PPP1R2
|
[NCBI]
|
8.13266e-06
|
|
|
COLQ
|
[NCBI]
|
8.13266e-06
|
|
|
GATA6
|
[NCBI]
|
8.13266e-06
|
|
|
TST
|
[NCBI]
|
8.13266e-06
|
|
|
GPR154
|
[NCBI]
|
8.13266e-06
|
|
|
CCL4L1
|
[NCBI]
|
8.13266e-06
|
|
|
CLCN2
|
[NCBI]
|
8.13266e-06
|
|
|
FUT6
|
[NCBI]
|
8.13266e-06
|
|
|
ROM1
|
[NCBI]
|
8.13266e-06
|
|
|
MEOX2
|
[NCBI]
|
8.13266e-06
|
|
|
PODXL
|
[NCBI]
|
8.13266e-06
|
|
|
CHRNG
|
[NCBI]
|
8.13266e-06
|
|
|
SLC7A7
|
[NCBI]
|
8.13266e-06
|
|
|
KLF3
|
[NCBI]
|
8.13266e-06
|
|
|
ME1
|
[NCBI]
|
8.13266e-06
|
|
|
KRT4
|
[NCBI]
|
8.13266e-06
|
|
|
SMC1A
|
[NCBI]
|
8.13266e-06
|
|
|
amyloidosis vi
|
[NCBI]
|
8.09562e-06
|
|
|
SAA1
|
[NCBI]
|
8.09159e-06
|
|
|
PPOX
|
[NCBI]
|
7.82915e-06
|
|
|
CFNS
|
[NCBI]
|
7.66825e-06
|
|
|
citrullinemia, classic
|
[NCBI]
|
7.66825e-06
|
|
|
charge syndrome
|
[NCBI]
|
7.66825e-06
|
|
|
hyperekplexia, hereditary
|
[NCBI]
|
7.66825e-06
|
|
|
NEM3
|
[NCBI]
|
7.66825e-06
|
|
|
TG
|
[NCBI]
|
7.60201e-06
|
|
|
TYRP1
|
[NCBI]
|
7.57644e-06
|
|
|
CYP2A6
|
[NCBI]
|
7.57644e-06
|
|
|
ICAM1
|
[NCBI]
|
7.57644e-06
|
|
|
CYP3A7
|
[NCBI]
|
7.46963e-06
|
|
|
ACR
|
[NCBI]
|
7.46963e-06
|
|
|
BDKRB2
|
[NCBI]
|
7.46963e-06
|
|
|
POR
|
[NCBI]
|
7.46963e-06
|
|
|
NEUROG3
|
[NCBI]
|
7.46963e-06
|
|
|
PDE11A
|
[NCBI]
|
7.46963e-06
|
|
|
CRLF1
|
[NCBI]
|
7.46963e-06
|
|
|
NME2
|
[NCBI]
|
7.46963e-06
|
|
|
PDE4A
|
[NCBI]
|
7.46963e-06
|
|
|
TDGF1
|
[NCBI]
|
7.46963e-06
|
|
|
SSTR1
|
[NCBI]
|
7.46963e-06
|
|
|
CASP10
|
[NCBI]
|
7.46963e-06
|
|
|
ADRA1B
|
[NCBI]
|
7.46963e-06
|
|
|
NTS
|
[NCBI]
|
7.46963e-06
|
|
|
MKKS
|
[NCBI]
|
7.46963e-06
|
|
|
ABCA2
|
[NCBI]
|
7.46963e-06
|
|
|
LMO7
|
[NCBI]
|
7.46963e-06
|
|
|
TRPC3
|
[NCBI]
|
7.46963e-06
|
|
|
HBQ1
|
[NCBI]
|
7.46963e-06
|
|
|
CACNB4
|
[NCBI]
|
7.46963e-06
|
|
|
MST1R
|
[NCBI]
|
7.46963e-06
|
|
|
IRF2
|
[NCBI]
|
7.46963e-06
|
|
|
BSCL2
|
[NCBI]
|
7.46963e-06
|
|
|
SEMA7A
|
[NCBI]
|
7.46963e-06
|
|
|
GP1BB
|
[NCBI]
|
7.46963e-06
|
|
|
PGAM1
|
[NCBI]
|
7.46963e-06
|
|
|
LAMC2
|
[NCBI]
|
7.46963e-06
|
|
|
GZMK
|
[NCBI]
|
7.46963e-06
|
|
|
GPD2
|
[NCBI]
|
7.46963e-06
|
|
|
MAF
|
[NCBI]
|
7.46963e-06
|
|
|
HTR2C
|
[NCBI]
|
7.46963e-06
|
|
|
ADCY1
|
[NCBI]
|
7.46963e-06
|
|
|
TEK
|
[NCBI]
|
7.46963e-06
|
|
|
GSTZ1
|
[NCBI]
|
7.46963e-06
|
|
|
NEUROG2
|
[NCBI]
|
7.46963e-06
|
|
|
PBEF1
|
[NCBI]
|
7.46963e-06
|
|
|
BCAT1
|
[NCBI]
|
7.46963e-06
|
|
|
PAI1
|
[NCBI]
|
7.33292e-06
|
|
|
LRRK2
|
[NCBI]
|
7.31376e-06
|
|
|
ACADM
|
[NCBI]
|
7.25308e-06
|
|
|
alopecia, androgenetic
|
[NCBI]
|
7.21857e-06
|
|
|
hepatocellular carcinoma
|
[NCBI]
|
7.16047e-06
|
|
|
LCA1
|
[NCBI]
|
7.16047e-06
|
|
|
pheochromocytoma
|
[NCBI]
|
7.16047e-06
|
|
|
osteoarthritis
|
[NCBI]
|
7.16047e-06
|
|
|
SLC26A4
|
[NCBI]
|
7.0981e-06
|
|
|
SDS
|
[NCBI]
|
6.94389e-06
|
|
|
BCNS
|
[NCBI]
|
6.90652e-06
|
|
|
KCNJ6
|
[NCBI]
|
6.88981e-06
|
|
|
SHANK3
|
[NCBI]
|
6.88981e-06
|
|
|
ELOVL4
|
[NCBI]
|
6.88981e-06
|
|
|
EPHX2
|
[NCBI]
|
6.88981e-06
|
|
|
NUMA1
|
[NCBI]
|
6.88981e-06
|
|
|
HTN3
|
[NCBI]
|
6.88981e-06
|
|
|
EDAR
|
[NCBI]
|
6.88981e-06
|
|
|
DSCAM
|
[NCBI]
|
6.88981e-06
|
|
|
SCNN1G
|
[NCBI]
|
6.88981e-06
|
|
|
farber lipogranulomatosis
|
[NCBI]
|
6.88981e-06
|
|
|
CHRNA7
|
[NCBI]
|
6.88981e-06
|
|
|
ZFPM2
|
[NCBI]
|
6.88981e-06
|
|
|
PHYH
|
[NCBI]
|
6.88981e-06
|
|
|
RPS4X
|
[NCBI]
|
6.88981e-06
|
|
|
CD19
|
[NCBI]
|
6.88981e-06
|
|
|
TFG
|
[NCBI]
|
6.88981e-06
|
|
|
TUB
|
[NCBI]
|
6.88981e-06
|
|
|
CNGB3
|
[NCBI]
|
6.88981e-06
|
|
|
ATP8B1
|
[NCBI]
|
6.88981e-06
|
|
|
PTGER2
|
[NCBI]
|
6.88981e-06
|
|
|
TNFRSF13C
|
[NCBI]
|
6.88981e-06
|
|
|
TTC10
|
[NCBI]
|
6.88981e-06
|
|
|
SREBF2
|
[NCBI]
|
6.88981e-06
|
|
|
TRPC1
|
[NCBI]
|
6.88981e-06
|
|
|
SHOX
|
[NCBI]
|
6.87153e-06
|
|
|
MICA
|
[NCBI]
|
6.87153e-06
|
|
|
TPI1
|
[NCBI]
|
6.87153e-06
|
|
|
DFNB1
|
[NCBI]
|
6.68354e-06
|
|
|
EVC
|
[NCBI]
|
6.68354e-06
|
|
|
FA
|
[NCBI]
|
6.66886e-06
|
|
|
EDNRB
|
[NCBI]
|
6.65279e-06
|
|
|
leber optic atrophy
|
[NCBI]
|
6.52176e-06
|
|
|
SMAX1
|
[NCBI]
|
6.48519e-06
|
|
|
TNFRSF1B
|
[NCBI]
|
6.4415e-06
|
|
|
SNCA
|
[NCBI]
|
6.42649e-06
|
|
|
HFM
|
[NCBI]
|
6.40917e-06
|
|
|
SPINK1
|
[NCBI]
|
6.40201e-06
|
|
|
apc gene
|
[NCBI]
|
6.40192e-06
|
|
|
DEFB4
|
[NCBI]
|
6.37646e-06
|
|
|
SLC17A5
|
[NCBI]
|
6.37646e-06
|
|
|
GYS1
|
[NCBI]
|
6.37646e-06
|
|
|
GP9
|
[NCBI]
|
6.37646e-06
|
|
|
NPPB
|
[NCBI]
|
6.37646e-06
|
|
|
CCL5
|
[NCBI]
|
6.37646e-06
|
|
|
DAP3
|
[NCBI]
|
6.37646e-06
|
|
|
SGCG
|
[NCBI]
|
6.37646e-06
|
|
|
SORD
|
[NCBI]
|
6.37646e-06
|
|
|
RPA1
|
[NCBI]
|
6.37646e-06
|
|
|
LAMA3
|
[NCBI]
|
6.37646e-06
|
|
|
MFNG
|
[NCBI]
|
6.37646e-06
|
|
|
SEMA3B
|
[NCBI]
|
6.37646e-06
|
|
|
CCNB1
|
[NCBI]
|
6.37646e-06
|
|
|
MTNR1A
|
[NCBI]
|
6.37646e-06
|
|
|
CFD
|
[NCBI]
|
6.37646e-06
|
|
|
RGS9
|
[NCBI]
|
6.37646e-06
|
|
|
HTR1B
|
[NCBI]
|
6.37646e-06
|
|
|
GAS6
|
[NCBI]
|
6.37646e-06
|
|
|
PDHA1
|
[NCBI]
|
6.23729e-06
|
|
|
PPSH
|
[NCBI]
|
6.23518e-06
|
|
|
myoclonic epilepsy of lafora
|
[NCBI]
|
6.23518e-06
|
|
|
temporal arteritis
|
[NCBI]
|
6.18771e-06
|
|
|
IL2
|
[NCBI]
|
6.1816e-06
|
|
|
MB
|
[NCBI]
|
6.17635e-06
|
|
|
SMA1
|
[NCBI]
|
6.16672e-06
|
|
|
MMP3
|
[NCBI]
|
6.03983e-06
|
|
|
BRIP1
|
[NCBI]
|
5.91745e-06
|
|
|
GABBR2
|
[NCBI]
|
5.91745e-06
|
|
|
tritanopia
|
[NCBI]
|
5.91745e-06
|
|
|
GOT2
|
[NCBI]
|
5.91745e-06
|
|
|
HPS1
|
[NCBI]
|
5.91745e-06
|
|
|
GLUL
|
[NCBI]
|
5.91745e-06
|
|
|
CX3CR1
|
[NCBI]
|
5.91745e-06
|
|
|
IGFBP1
|
[NCBI]
|
5.91745e-06
|
|
|
ORM2
|
[NCBI]
|
5.91745e-06
|
|
|
KIR2DL1
|
[NCBI]
|
5.91745e-06
|
|
|
UBQLN1
|
[NCBI]
|
5.91745e-06
|
|
|
ERAF
|
[NCBI]
|
5.91745e-06
|
|
|
RAB7
|
[NCBI]
|
5.91745e-06
|
|
|
DIO2
|
[NCBI]
|
5.91745e-06
|
|
|
ECGF1
|
[NCBI]
|
5.91745e-06
|
|
|
RPS12
|
[NCBI]
|
5.91745e-06
|
|
|
DNM2
|
[NCBI]
|
5.91745e-06
|
|
|
KCNQ4
|
[NCBI]
|
5.91745e-06
|
|
|
TTPA
|
[NCBI]
|
5.91745e-06
|
|
|
ALDH3A1
|
[NCBI]
|
5.91745e-06
|
|
|
PON2
|
[NCBI]
|
5.91745e-06
|
|
|
PMCH
|
[NCBI]
|
5.88093e-06
|
|
|
HEXB
|
[NCBI]
|
5.84881e-06
|
|
|
GLA
|
[NCBI]
|
5.84881e-06
|
|
|
LPA
|
[NCBI]
|
5.84881e-06
|
|
|
AMACR
|
[NCBI]
|
5.84881e-06
|
|
|
MTCYB
|
[NCBI]
|
5.84881e-06
|
|
|
pyruvate decarboxylase deficiency
|
[NCBI]
|
5.81334e-06
|
|
|
apert syndrome
|
[NCBI]
|
5.81334e-06
|
|
|
KCNH2
|
[NCBI]
|
5.78067e-06
|
|
|
JAK2
|
[NCBI]
|
5.78067e-06
|
|
|
SHBG
|
[NCBI]
|
5.72636e-06
|
|
|
ENG
|
[NCBI]
|
5.66395e-06
|
|
|
SOX9
|
[NCBI]
|
5.66395e-06
|
|
|
VHL
|
[NCBI]
|
5.6387e-06
|
|
|
HPS
|
[NCBI]
|
5.59537e-06
|
|
|
ASCL1
|
[NCBI]
|
5.50368e-06
|
|
|
IDH1
|
[NCBI]
|
5.50368e-06
|
|
|
WWOX
|
[NCBI]
|
5.50368e-06
|
|
|
MOG
|
[NCBI]
|
5.50368e-06
|
|
|
GRM1
|
[NCBI]
|
5.50368e-06
|
|
|
OTX2
|
[NCBI]
|
5.50368e-06
|
|
|
CRYGC
|
[NCBI]
|
5.50368e-06
|
|
|
CDC25A
|
[NCBI]
|
5.50368e-06
|
|
|
ZNF198
|
[NCBI]
|
5.50368e-06
|
|
|
LTA4H
|
[NCBI]
|
5.50368e-06
|
|
|
CD209
|
[NCBI]
|
5.50368e-06
|
|
|
NDRG1
|
[NCBI]
|
5.50368e-06
|
|
|
CLCN7
|
[NCBI]
|
5.50368e-06
|
|
|
SALL4
|
[NCBI]
|
5.50368e-06
|
|
|
TFE3
|
[NCBI]
|
5.50368e-06
|
|
|
NRF1
|
[NCBI]
|
5.50368e-06
|
|
|
SULT1A1
|
[NCBI]
|
5.50368e-06
|
|
|
KRT8
|
[NCBI]
|
5.50368e-06
|
|
|
OCRL
|
[NCBI]
|
5.50368e-06
|
|
|
PAPSS2
|
[NCBI]
|
5.50368e-06
|
|
|
DYRK1A
|
[NCBI]
|
5.50368e-06
|
|
|
TCRA
|
[NCBI]
|
5.48496e-06
|
|
|
MCOPS7
|
[NCBI]
|
5.41619e-06
|
|
|
homocysteinemia
|
[NCBI]
|
5.41619e-06
|
|
|
HHC1
|
[NCBI]
|
5.41619e-06
|
|
|
MAFD2
|
[NCBI]
|
5.36908e-06
|
|
|
STAR
|
[NCBI]
|
5.36516e-06
|
|
|
MTATP6
|
[NCBI]
|
5.31161e-06
|
|
|
INSR
|
[NCBI]
|
5.30288e-06
|
|
|
CREBBP
|
[NCBI]
|
5.14364e-06
|
|
|
L1CAM
|
[NCBI]
|
5.14364e-06
|
|
|
factor x deficiency
|
[NCBI]
|
5.14364e-06
|
|
|
DAZL
|
[NCBI]
|
5.12818e-06
|
|
|
CHST3
|
[NCBI]
|
5.12818e-06
|
|
|
ITGA2
|
[NCBI]
|
5.12818e-06
|
|
|
IKBKAP
|
[NCBI]
|
5.12818e-06
|
|
|
MTHFD1
|
[NCBI]
|
5.12818e-06
|
|
|
prekallikrein deficiency
|
[NCBI]
|
5.12818e-06
|
|
|
ATXN2
|
[NCBI]
|
5.12818e-06
|
|
|
FCGR2A
|
[NCBI]
|
5.12818e-06
|
|
|
GRIN2B
|
[NCBI]
|
5.12818e-06
|
|
|
DUOX2
|
[NCBI]
|
5.12818e-06
|
|
|
ONECUT1
|
[NCBI]
|
5.12818e-06
|
|
|
SFTPA1
|
[NCBI]
|
5.12818e-06
|
|
|
OLR1
|
[NCBI]
|
5.12818e-06
|
|
|
alsin
|
[NCBI]
|
5.12818e-06
|
|
|
AQP7
|
[NCBI]
|
5.12818e-06
|
|
|
CALCR
|
[NCBI]
|
5.12818e-06
|
|
|
NCL
|
[NCBI]
|
5.12818e-06
|
|
|
NQO1
|
[NCBI]
|
5.12818e-06
|
|
|
tyrosine transaminase deficiency
|
[NCBI]
|
5.12818e-06
|
|
|
PRPS1
|
[NCBI]
|
5.12818e-06
|
|
|
KCNJ1
|
[NCBI]
|
5.12818e-06
|
|
|
PDE4D
|
[NCBI]
|
5.12818e-06
|
|
|
HFE
|
[NCBI]
|
5.08399e-06
|
|
|
FPLD2
|
[NCBI]
|
5.04209e-06
|
|
|
RBS
|
[NCBI]
|
5.04209e-06
|
|
|
GJB2
|
[NCBI]
|
5.00914e-06
|
|
|
TLR5
|
[NCBI]
|
4.98084e-06
|
|
|
ALK
|
[NCBI]
|
4.89999e-06
|
|
|
RHO
|
[NCBI]
|
4.85642e-06
|
|
|
PRF1
|
[NCBI]
|
4.823e-06
|
|
|
AURKA
|
[NCBI]
|
4.78545e-06
|
|
|
FUT1
|
[NCBI]
|
4.78545e-06
|
|
|
CCL18
|
[NCBI]
|
4.78545e-06
|
|
|
PCSK9
|
[NCBI]
|
4.78545e-06
|
|
|
AHCY
|
[NCBI]
|
4.78545e-06
|
|
|
GRB10
|
[NCBI]
|
4.78545e-06
|
|
|
RHAG
|
[NCBI]
|
4.78545e-06
|
|
|
MTMR2
|
[NCBI]
|
4.78545e-06
|
|
|
SLC25A1
|
[NCBI]
|
4.78545e-06
|
|
|
DVL1
|
[NCBI]
|
4.78545e-06
|
|
|
ETF1
|
[NCBI]
|
4.78545e-06
|
|
|
PLA2G7
|
[NCBI]
|
4.78545e-06
|
|
|
CLEC4M
|
[NCBI]
|
4.78545e-06
|
|
|
OGG1
|
[NCBI]
|
4.78545e-06
|
|
|
DCTN1
|
[NCBI]
|
4.78545e-06
|
|
|
KRT10
|
[NCBI]
|
4.78545e-06
|
|
|
FOLR1
|
[NCBI]
|
4.78545e-06
|
|
|
CCL3
|
[NCBI]
|
4.78545e-06
|
|
|
NEFH
|
[NCBI]
|
4.78545e-06
|
|
|
CACNA1F
|
[NCBI]
|
4.78545e-06
|
|
|
periodic fever, familial, autosomal dominant
|
[NCBI]
|
4.68954e-06
|
|
|
gastric cancer
|
[NCBI]
|
4.68954e-06
|
|
|
factor vii deficiency
|
[NCBI]
|
4.66992e-06
|
|
|
EPOR
|
[NCBI]
|
4.52555e-06
|
|
|
PVR
|
[NCBI]
|
4.52142e-06
|
|
|
UCP1
|
[NCBI]
|
4.52092e-06
|
|
|
OPRM1
|
[NCBI]
|
4.51166e-06
|
|
|
GDAP1
|
[NCBI]
|
4.47113e-06
|
|
|
MTA1
|
[NCBI]
|
4.47113e-06
|
|
|
PDCD1
|
[NCBI]
|
4.47113e-06
|
|
|
PDC
|
[NCBI]
|
4.47113e-06
|
|
|
AGL
|
[NCBI]
|
4.47113e-06
|
|
|
SLC26A3
|
[NCBI]
|
4.47113e-06
|
|
|
RPS3
|
[NCBI]
|
4.47113e-06
|
|
|
NAGLU
|
[NCBI]
|
4.47113e-06
|
|
|
OTOF
|
[NCBI]
|
4.47113e-06
|
|
|
LIG4
|
[NCBI]
|
4.47113e-06
|
|
|
MTND4L
|
[NCBI]
|
4.47113e-06
|
|
|
APOA4
|
[NCBI]
|
4.47113e-06
|
|
|
LOR
|
[NCBI]
|
4.47113e-06
|
|
|
CCKAR
|
[NCBI]
|
4.47113e-06
|
|
|
FOXA2
|
[NCBI]
|
4.47113e-06
|
|
|
POU5F1
|
[NCBI]
|
4.47113e-06
|
|
|
NTRK3
|
[NCBI]
|
4.47113e-06
|
|
|
ACTB
|
[NCBI]
|
4.47113e-06
|
|
|
F13A1
|
[NCBI]
|
4.37733e-06
|
|
|
FH
|
[NCBI]
|
4.37733e-06
|
|
|
LGMD2A
|
[NCBI]
|
4.35721e-06
|
|
|
CVS
|
[NCBI]
|
4.35721e-06
|
|
|
PGL1
|
[NCBI]
|
4.35721e-06
|
|
|
PARK2
|
[NCBI]
|
4.35721e-06
|
|
|
B2M
|
[NCBI]
|
4.23747e-06
|
|
|
TLR4
|
[NCBI]
|
4.19955e-06
|
|
|
NFKBIA
|
[NCBI]
|
4.18164e-06
|
|
|
PRKCA
|
[NCBI]
|
4.18164e-06
|
|
|
CDC25C
|
[NCBI]
|
4.18164e-06
|
|
|
CYP1A2
|
[NCBI]
|
4.18164e-06
|
|
|
FLG
|
[NCBI]
|
4.18164e-06
|
|
|
LAMP2
|
[NCBI]
|
4.18164e-06
|
|
|
ANGPT1
|
[NCBI]
|
4.18164e-06
|
|
|
GJD2
|
[NCBI]
|
4.18164e-06
|
|
|
ALOX5
|
[NCBI]
|
4.18164e-06
|
|
|
TERF1
|
[NCBI]
|
4.18164e-06
|
|
|
COL18A1
|
[NCBI]
|
4.18164e-06
|
|
|
NPHS1
|
[NCBI]
|
4.18164e-06
|
|
|
THBD
|
[NCBI]
|
4.18164e-06
|
|
|
CYP2C9
|
[NCBI]
|
4.18164e-06
|
|
|
LYST
|
[NCBI]
|
4.18164e-06
|
|
|
ATP1A2
|
[NCBI]
|
4.18164e-06
|
|
|
GRIN2A
|
[NCBI]
|
4.18164e-06
|
|
|
SLC19A1
|
[NCBI]
|
4.18164e-06
|
|
|
PCD
|
[NCBI]
|
4.10653e-06
|
|
|
ABL1
|
[NCBI]
|
4.10169e-06
|
|
|
MECP2
|
[NCBI]
|
4.05135e-06
|
|
|
CML
|
[NCBI]
|
4.04386e-06
|
|
|
EVA
|
[NCBI]
|
4.04386e-06
|
|
|
GHRH
|
[NCBI]
|
4.00116e-06
|
|
|
OTC
|
[NCBI]
|
3.96985e-06
|
|
|
CRX
|
[NCBI]
|
3.91407e-06
|
|
|
ATXN7
|
[NCBI]
|
3.91407e-06
|
|
|
NR5A2
|
[NCBI]
|
3.91407e-06
|
|
|
CAST
|
[NCBI]
|
3.91407e-06
|
|
|
CSH1
|
[NCBI]
|
3.91407e-06
|
|
|
CALM1
|
[NCBI]
|
3.91407e-06
|
|
|
SLC22A8
|
[NCBI]
|
3.91407e-06
|
|
|
C7
|
[NCBI]
|
3.91407e-06
|
|
|
PAK2
|
[NCBI]
|
3.91407e-06
|
|
|
CBR1
|
[NCBI]
|
3.91407e-06
|
|
|
SCNN1A
|
[NCBI]
|
3.91407e-06
|
|
|
IL7R
|
[NCBI]
|
3.91407e-06
|
|
|
COL11A1
|
[NCBI]
|
3.91407e-06
|
|
|
RAD51
|
[NCBI]
|
3.91407e-06
|
|
|
CYP11A1
|
[NCBI]
|
3.91407e-06
|
|
|
PLP1
|
[NCBI]
|
3.84181e-06
|
|
|
CDPX2
|
[NCBI]
|
3.74838e-06
|
|
|
OCA2
|
[NCBI]
|
3.74838e-06
|
|
|
walker-warburg syndrome
|
[NCBI]
|
3.74838e-06
|
|
|
MM
|
[NCBI]
|
3.74838e-06
|
|
|
meningioma, familial
|
[NCBI]
|
3.74838e-06
|
|
|
CADASIL
|
[NCBI]
|
3.74838e-06
|
|
|
PSEN2
|
[NCBI]
|
3.71743e-06
|
|
|
UCHL1
|
[NCBI]
|
3.66597e-06
|
|
|
G6PC2
|
[NCBI]
|
3.66597e-06
|
|
|
TPM3
|
[NCBI]
|
3.66597e-06
|
|
|
CBP
|
[NCBI]
|
3.66597e-06
|
|
|
PTS
|
[NCBI]
|
3.66597e-06
|
|
|
TGM2
|
[NCBI]
|
3.66597e-06
|
|
|
JK
|
[NCBI]
|
3.66597e-06
|
|
|
ADSL
|
[NCBI]
|
3.66597e-06
|
|
|
ITGB4
|
[NCBI]
|
3.66597e-06
|
|
|
FOXC1
|
[NCBI]
|
3.66597e-06
|
|
|
ALDOA
|
[NCBI]
|
3.66597e-06
|
|
|
GLRA1
|
[NCBI]
|
3.66597e-06
|
|
|
EPB42
|
[NCBI]
|
3.66597e-06
|
|
|
SPG7
|
[NCBI]
|
3.66597e-06
|
|
|
ANGPT2
|
[NCBI]
|
3.66597e-06
|
|
|
SLC2A2
|
[NCBI]
|
3.59659e-06
|
|
|
RPGR
|
[NCBI]
|
3.59659e-06
|
|
|
CPB2
|
[NCBI]
|
3.49316e-06
|
|
|
KSS
|
[NCBI]
|
3.47741e-06
|
|
|
SMA3
|
[NCBI]
|
3.46975e-06
|
|
|
GCPS
|
[NCBI]
|
3.46975e-06
|
|
|
CMTX1
|
[NCBI]
|
3.46975e-06
|
|
|
kartagener syndrome
|
[NCBI]
|
3.46975e-06
|
|
|
DNMT1
|
[NCBI]
|
3.44805e-06
|
|
|
3-@beta-hydroxysteroid dehydrogenase, type ii, deficiency of
|
[NCBI]
|
3.43529e-06
|
|
|
NR4A2
|
[NCBI]
|
3.43529e-06
|
|
|
RETN
|
[NCBI]
|
3.43529e-06
|
|
|
SGCE
|
[NCBI]
|
3.43529e-06
|
|
|
PGM3
|
[NCBI]
|
3.43529e-06
|
|
|
CRHR1
|
[NCBI]
|
3.43529e-06
|
|
|
PTPN22
|
[NCBI]
|
3.43529e-06
|
|
|
COL11A2
|
[NCBI]
|
3.43529e-06
|
|
|
FGF9
|
[NCBI]
|
3.43529e-06
|
|
|
HADHA
|
[NCBI]
|
3.43529e-06
|
|
|
TNFRSF13B
|
[NCBI]
|
3.43529e-06
|
|
|
TERF2
|
[NCBI]
|
3.43529e-06
|
|
|
AHR
|
[NCBI]
|
3.36829e-06
|
|
|
IGF1
|
[NCBI]
|
3.36506e-06
|
|
|
ABCG2
|
[NCBI]
|
3.34941e-06
|
|
|
MTND4
|
[NCBI]
|
3.25415e-06
|
|
|
PKD2
|
[NCBI]
|
3.25415e-06
|
|
|
EPB41
|
[NCBI]
|
3.22029e-06
|
|
|
NNMT
|
[NCBI]
|
3.22029e-06
|
|
|
udp-n-acetylglucosamine 2-epimerase/n-acetylmannosamine kinase
|
[NCBI]
|
3.22029e-06
|
|
|
NR4A3
|
[NCBI]
|
3.22029e-06
|
|
|
IGHV
|
[NCBI]
|
3.22029e-06
|
|
|
CYP2C19
|
[NCBI]
|
3.22029e-06
|
|
|
CSF1
|
[NCBI]
|
3.22029e-06
|
|
|
NEB
|
[NCBI]
|
3.22029e-06
|
|
|
ERCC6
|
[NCBI]
|
3.22029e-06
|
|
|
RELA
|
[NCBI]
|
3.22029e-06
|
|
|
NCSTN
|
[NCBI]
|
3.22029e-06
|
|
|
CEACAM6
|
[NCBI]
|
3.22029e-06
|
|
|
phenylketonuria ii
|
[NCBI]
|
3.22029e-06
|
|
|
COH1
|
[NCBI]
|
3.20703e-06
|
|
|
ATS
|
[NCBI]
|
3.20703e-06
|
|
|
hemophilia a
|
[NCBI]
|
3.15442e-06
|
|
|
cortisol 11-beta-ketoreductase deficiency
|
[NCBI]
|
3.14634e-06
|
|
|
PD
|
[NCBI]
|
3.11764e-06
|
|
|
CYP19A1
|
[NCBI]
|
3.04152e-06
|
|
|
MAP4
|
[NCBI]
|
3.01948e-06
|
|
|
USF2
|
[NCBI]
|
3.01948e-06
|
|
|
PEX7
|
[NCBI]
|
3.01948e-06
|
|
|
PYGM
|
[NCBI]
|
3.01948e-06
|
|
|
NME1
|
[NCBI]
|
3.01948e-06
|
|
|
HR
|
[NCBI]
|
3.01948e-06
|
|
|
CLCN5
|
[NCBI]
|
3.01948e-06
|
|
|
SLC2A1
|
[NCBI]
|
3.01948e-06
|
|
|
SSTR2
|
[NCBI]
|
3.01948e-06
|
|
|
GPR54
|
[NCBI]
|
3.01948e-06
|
|
|
LDLR
|
[NCBI]
|
2.9915e-06
|
|
|
GLC1A
|
[NCBI]
|
2.95935e-06
|
|
|
myoclonic epilepsy of unverricht and lundborg
|
[NCBI]
|
2.95935e-06
|
|
|
aHUS
|
[NCBI]
|
2.95935e-06
|
|
|
PDS
|
[NCBI]
|
2.95935e-06
|
|
|
mucolipidosis ii
|
[NCBI]
|
2.95935e-06
|
|
|
BTC
|
[NCBI]
|
2.93961e-06
|
|
|
ABP1
|
[NCBI]
|
2.91516e-06
|
|
|
DRPLA
|
[NCBI]
|
2.88754e-06
|
|
|
ELN
|
[NCBI]
|
2.84052e-06
|
|
|
GHSR
|
[NCBI]
|
2.83155e-06
|
|
|
DBH
|
[NCBI]
|
2.83155e-06
|
|
|
ATP2A2
|
[NCBI]
|
2.83155e-06
|
|
|
PDGFRA
|
[NCBI]
|
2.83155e-06
|
|
|
AMPD1
|
[NCBI]
|
2.83155e-06
|
|
|
FOXC2
|
[NCBI]
|
2.83155e-06
|
|
|
SYP
|
[NCBI]
|
2.83155e-06
|
|
|
F12
|
[NCBI]
|
2.83155e-06
|
|
|
EBP
|
[NCBI]
|
2.83155e-06
|
|
|
TPO
|
[NCBI]
|
2.79903e-06
|
|
|
AIS
|
[NCBI]
|
2.77519e-06
|
|
|
PLTP
|
[NCBI]
|
2.7741e-06
|
|
|
ACH
|
[NCBI]
|
2.77164e-06
|
|
|
CD36
|
[NCBI]
|
2.74416e-06
|
|
|
ABCC8
|
[NCBI]
|
2.7313e-06
|
|
|
CD
|
[NCBI]
|
2.73031e-06
|
|
|
FGFR3
|
[NCBI]
|
2.70372e-06
|
|
|
RNASE2
|
[NCBI]
|
2.66261e-06
|
|
|
UBE3A
|
[NCBI]
|
2.6554e-06
|
|
|
CTSB
|
[NCBI]
|
2.6554e-06
|
|
|
SDHD
|
[NCBI]
|
2.6554e-06
|
|
|
AACT
|
[NCBI]
|
2.6554e-06
|
|
|
H3F3A
|
[NCBI]
|
2.6554e-06
|
|
|
APTX
|
[NCBI]
|
2.6554e-06
|
|
|
GJB3
|
[NCBI]
|
2.6554e-06
|
|
|
WFS1
|
[NCBI]
|
2.6554e-06
|
|
|
LAMB3
|
[NCBI]
|
2.6554e-06
|
|
|
GCCR
|
[NCBI]
|
2.65045e-06
|
|
|
CPI
|
[NCBI]
|
2.5678e-06
|
|
|
PPARA
|
[NCBI]
|
2.55785e-06
|
|
|
POAG
|
[NCBI]
|
2.50606e-06
|
|
|
MTS
|
[NCBI]
|
2.50606e-06
|
|
|
FOP
|
[NCBI]
|
2.50606e-06
|
|
|
hypophosphatemic rickets, x-linked dominant
|
[NCBI]
|
2.50606e-06
|
|
|
CDSN
|
[NCBI]
|
2.49003e-06
|
|
|
PMM2
|
[NCBI]
|
2.49003e-06
|
|
|
MSX1
|
[NCBI]
|
2.49003e-06
|
|
|
CDH23
|
[NCBI]
|
2.49003e-06
|
|
|
LDHA
|
[NCBI]
|
2.49003e-06
|
|
|
TRAF6
|
[NCBI]
|
2.49003e-06
|
|
|
DRPLA
|
[NCBI]
|
2.49003e-06
|
|
|
MFN2
|
[NCBI]
|
2.49003e-06
|
|
|
OSBP
|
[NCBI]
|
2.49003e-06
|
|
|
NR1I2
|
[NCBI]
|
2.45902e-06
|
|
|
DHFR
|
[NCBI]
|
2.40951e-06
|
|
|
APC
|
[NCBI]
|
2.40681e-06
|
|
|
FGF2
|
[NCBI]
|
2.36296e-06
|
|
|
FKRP
|
[NCBI]
|
2.33459e-06
|
|
|
CLOCK
|
[NCBI]
|
2.33459e-06
|
|
|
LRP5
|
[NCBI]
|
2.33459e-06
|
|
|
IP
|
[NCBI]
|
2.33367e-06
|
|
|
BMD
|
[NCBI]
|
2.29902e-06
|
|
|
RSTS
|
[NCBI]
|
2.29902e-06
|
|
|
CYP1A1
|
[NCBI]
|
2.27098e-06
|
|
|
MAPT
|
[NCBI]
|
2.21627e-06
|
|
|
RB1
|
[NCBI]
|
2.2132e-06
|
|
|
EXT1
|
[NCBI]
|
2.18831e-06
|
|
|
PMS2
|
[NCBI]
|
2.18831e-06
|
|
|
pta deficiency
|
[NCBI]
|
2.18831e-06
|
|
|
HPX
|
[NCBI]
|
2.18831e-06
|
|
|
MTND2
|
[NCBI]
|
2.18831e-06
|
|
|
PAX2
|
[NCBI]
|
2.18831e-06
|
|
|
BMP15
|
[NCBI]
|
2.18831e-06
|
|
|
CDKN1C
|
[NCBI]
|
2.18831e-06
|
|
|
TS
|
[NCBI]
|
2.17354e-06
|
|
|
CCND1
|
[NCBI]
|
2.15719e-06
|
|
|
HMBS
|
[NCBI]
|
2.14294e-06
|
|
|
NR0B2
|
[NCBI]
|
2.13978e-06
|
|
|
FSHR
|
[NCBI]
|
2.13978e-06
|
|
|
FRDA
|
[NCBI]
|
2.12518e-06
|
|
|
HSAN3
|
[NCBI]
|
2.10421e-06
|
|
|
LCAT
|
[NCBI]
|
2.07455e-06
|
|
|
SLC4A1
|
[NCBI]
|
2.06264e-06
|
|
|
AGER
|
[NCBI]
|
2.05672e-06
|
|
|
PPARGC1A
|
[NCBI]
|
2.05051e-06
|
|
|
ATF6
|
[NCBI]
|
2.05051e-06
|
|
|
AHSG
|
[NCBI]
|
2.05051e-06
|
|
|
NOS1
|
[NCBI]
|
2.05051e-06
|
|
|
HM13
|
[NCBI]
|
2.05051e-06
|
|
|
CD4
|
[NCBI]
|
2.05051e-06
|
|
|
CMH
|
[NCBI]
|
2.02368e-06
|
|
|
ADHD
|
[NCBI]
|
1.96166e-06
|
|
|
DBI
|
[NCBI]
|
1.9294e-06
|
|
|
porphyria, acute intermittent
|
[NCBI]
|
1.92104e-06
|
|
|
JPS
|
[NCBI]
|
1.92104e-06
|
|
|
CHRNE
|
[NCBI]
|
1.92058e-06
|
|
|
adenylyl cyclase, soluble
|
[NCBI]
|
1.92058e-06
|
|
|
CES1
|
[NCBI]
|
1.92058e-06
|
|
|
PTCH1
|
[NCBI]
|
1.92058e-06
|
|
|
PRG4
|
[NCBI]
|
1.92058e-06
|
|
|
ITGA2B
|
[NCBI]
|
1.92058e-06
|
|
|
IFNGR1
|
[NCBI]
|
1.92058e-06
|
|
|
MLH1
|
[NCBI]
|
1.91466e-06
|
|
|
RYR1
|
[NCBI]
|
1.84371e-06
|
|
|
TBP
|
[NCBI]
|
1.80458e-06
|
|
|
LFNG
|
[NCBI]
|
1.79799e-06
|
|
|
APEX
|
[NCBI]
|
1.79799e-06
|
|
|
BACE1
|
[NCBI]
|
1.79799e-06
|
|
|
TNFRSF10A
|
[NCBI]
|
1.79799e-06
|
|
|
PRSS1
|
[NCBI]
|
1.79799e-06
|
|
|
CD2AP
|
[NCBI]
|
1.79799e-06
|
|
|
IGF2R
|
[NCBI]
|
1.79799e-06
|
|
|
LRP1
|
[NCBI]
|
1.78485e-06
|
|
|
APRT
|
[NCBI]
|
1.78018e-06
|
|
|
BMP2
|
[NCBI]
|
1.77471e-06
|
|
|
PGR
|
[NCBI]
|
1.75053e-06
|
|
|
ABL
|
[NCBI]
|
1.74898e-06
|
|
|
SOD2
|
[NCBI]
|
1.73533e-06
|
|
|
FGFR1
|
[NCBI]
|
1.72333e-06
|
|
|
TTN
|
[NCBI]
|
1.68224e-06
|
|
|
GSTP1
|
[NCBI]
|
1.68224e-06
|
|
|
GP1BA
|
[NCBI]
|
1.68224e-06
|
|
|
XPC
|
[NCBI]
|
1.68224e-06
|
|
|
CAV1
|
[NCBI]
|
1.68224e-06
|
|
|
TNFSF8
|
[NCBI]
|
1.68224e-06
|
|
|
NOS2A
|
[NCBI]
|
1.68224e-06
|
|
|
CP
|
[NCBI]
|
1.64619e-06
|
|
|
VHL
|
[NCBI]
|
1.63678e-06
|
|
|
sotos syndrome
|
[NCBI]
|
1.5875e-06
|
|
|
ARNT
|
[NCBI]
|
1.57898e-06
|
|
|
HRG
|
[NCBI]
|
1.57898e-06
|
|
|
complement component 6 deficiency
|
[NCBI]
|
1.57289e-06
|
|
|
PRODH
|
[NCBI]
|
1.57289e-06
|
|
|
GRIN1
|
[NCBI]
|
1.57289e-06
|
|
|
RBP4
|
[NCBI]
|
1.57289e-06
|
|
|
ATXN1
|
[NCBI]
|
1.57289e-06
|
|
|
CYP11B2
|
[NCBI]
|
1.57289e-06
|
|
|
adrenal hyperplasia, congenital, due to 21-hydroxylase deficiency
|
[NCBI]
|
1.55966e-06
|
|
|
TLR2
|
[NCBI]
|
1.50336e-06
|
|
|
glycogen storage disease ixa
|
[NCBI]
|
1.46954e-06
|
|
|
MET
|
[NCBI]
|
1.46954e-06
|
|
|
PTPN11
|
[NCBI]
|
1.46954e-06
|
|
|
CAPN3
|
[NCBI]
|
1.46954e-06
|
|
|
COL6A1
|
[NCBI]
|
1.46954e-06
|
|
|
ALPL
|
[NCBI]
|
1.46954e-06
|
|
|
IL1A
|
[NCBI]
|
1.46954e-06
|
|
|
IL18
|
[NCBI]
|
1.46954e-06
|
|
|
fructose intolerance, hereditary
|
[NCBI]
|
1.46954e-06
|
|
|
MTRNR1
|
[NCBI]
|
1.46954e-06
|
|
|
ALD
|
[NCBI]
|
1.4179e-06
|
|
|
KRT5
|
[NCBI]
|
1.37182e-06
|
|
|
MAOB
|
[NCBI]
|
1.37182e-06
|
|
|
MTND6
|
[NCBI]
|
1.37182e-06
|
|
|
DYSF
|
[NCBI]
|
1.37182e-06
|
|
|
MTND5
|
[NCBI]
|
1.37182e-06
|
|
|
COL10A1
|
[NCBI]
|
1.37182e-06
|
|
|
giant platelet syndrome
|
[NCBI]
|
1.36777e-06
|
|
|
CMT1B
|
[NCBI]
|
1.2945e-06
|
|
|
NPS
|
[NCBI]
|
1.2945e-06
|
|
|
CSA
|
[NCBI]
|
1.2945e-06
|
|
|
IL5
|
[NCBI]
|
1.27942e-06
|
|
|
SOX10
|
[NCBI]
|
1.27942e-06
|
|
|
DNMT3B
|
[NCBI]
|
1.27942e-06
|
|
|
CFI
|
[NCBI]
|
1.27942e-06
|
|
|
MITF
|
[NCBI]
|
1.25842e-06
|
|
|
DMD
|
[NCBI]
|
1.23447e-06
|
|
|
HD
|
[NCBI]
|
1.21151e-06
|
|
|
GLB1
|
[NCBI]
|
1.19201e-06
|
|
|
MTTK
|
[NCBI]
|
1.19201e-06
|
|
|
PEPD
|
[NCBI]
|
1.19201e-06
|
|
|
NBS1
|
[NCBI]
|
1.19201e-06
|
|
|
CDK6
|
[NCBI]
|
1.19201e-06
|
|
|
SPG4
|
[NCBI]
|
1.19201e-06
|
|
|
FABP3
|
[NCBI]
|
1.19201e-06
|
|
|
anemia, sideroblastic, x-linked
|
[NCBI]
|
1.19201e-06
|
|
|
hypertrophic neuropathy of dejerine-sottas
|
[NCBI]
|
1.16211e-06
|
|
|
BGLAP
|
[NCBI]
|
1.11215e-06
|
|
|
CXCR4
|
[NCBI]
|
1.10933e-06
|
|
|
PIGA
|
[NCBI]
|
1.10933e-06
|
|
|
STAT5B
|
[NCBI]
|
1.10933e-06
|
|
|
GDXY
|
[NCBI]
|
1.10933e-06
|
|
|
OA1
|
[NCBI]
|
1.10933e-06
|
|
|
polycystic kidneys
|
[NCBI]
|
1.09258e-06
|
|
|
HLA-A
|
[NCBI]
|
1.08312e-06
|
|
|
MJD
|
[NCBI]
|
1.04343e-06
|
|
|
WHS
|
[NCBI]
|
1.0395e-06
|
|
|
CDLS1
|
[NCBI]
|
1.0395e-06
|
|
|
HNPP
|
[NCBI]
|
1.03861e-06
|
|
|
NF2
|
[NCBI]
|
1.03861e-06
|
|
|
down syndrome
|
[NCBI]
|
1.03861e-06
|
|
|
GRA
|
[NCBI]
|
1.03861e-06
|
|
|
ABCC6
|
[NCBI]
|
1.03112e-06
|
|
|
CTCF
|
[NCBI]
|
1.03112e-06
|
|
|
coproporphyria
|
[NCBI]
|
1.03112e-06
|
|
|
PDGFB
|
[NCBI]
|
1.03112e-06
|
|
|
GATA1
|
[NCBI]
|
1.03112e-06
|
|
|
BCL6
|
[NCBI]
|
1.03112e-06
|
|
|
FAAH
|
[NCBI]
|
9.8994e-07
|
|
|
COL2A1
|
[NCBI]
|
9.8962e-07
|
|
|
LTA
|
[NCBI]
|
9.57137e-07
|
|
|
ornithine aminotransferase deficiency
|
[NCBI]
|
9.57137e-07
|
|
|
MTCO1
|
[NCBI]
|
9.57137e-07
|
|
|
GK
|
[NCBI]
|
9.57137e-07
|
|
|
TLR9
|
[NCBI]
|
9.43278e-07
|
|
|
CCM
|
[NCBI]
|
9.23628e-07
|
|
|
AN2
|
[NCBI]
|
9.23628e-07
|
|
|
PAM
|
[NCBI]
|
9.10227e-07
|
|
|
ADRB2
|
[NCBI]
|
8.87174e-07
|
|
|
PEMT
|
[NCBI]
|
8.87174e-07
|
|
|
wolman disease
|
[NCBI]
|
8.87174e-07
|
|
|
ABO
|
[NCBI]
|
8.87174e-07
|
|
|
AT
|
[NCBI]
|
8.85649e-07
|
|
|
EV
|
[NCBI]
|
8.59396e-07
|
|
|
RHCE
|
[NCBI]
|
8.21025e-07
|
|
|
HNMT
|
[NCBI]
|
8.21025e-07
|
|
|
SLC1A2
|
[NCBI]
|
8.21025e-07
|
|
|
fabry disease
|
[NCBI]
|
8.17767e-07
|
|
|
SCA7
|
[NCBI]
|
8.16834e-07
|
|
|
IL6
|
[NCBI]
|
7.74868e-07
|
|
|
FMR1
|
[NCBI]
|
7.67364e-07
|
|
|
GNMT
|
[NCBI]
|
7.58506e-07
|
|
|
SMN2
|
[NCBI]
|
7.58506e-07
|
|
|
ATP7B
|
[NCBI]
|
7.58506e-07
|
|
|
DES
|
[NCBI]
|
7.58506e-07
|
|
|
LIF
|
[NCBI]
|
7.58506e-07
|
|
|
GRN
|
[NCBI]
|
7.58506e-07
|
|
|
APS1
|
[NCBI]
|
7.48795e-07
|
|
|
ARPKD
|
[NCBI]
|
7.17902e-07
|
|
|
DMD
|
[NCBI]
|
7.17142e-07
|
|
|
MST1
|
[NCBI]
|
6.99444e-07
|
|
|
CSF2
|
[NCBI]
|
6.99444e-07
|
|
|
SIRT1
|
[NCBI]
|
6.99444e-07
|
|
|
GAA
|
[NCBI]
|
6.99444e-07
|
|
|
GTS
|
[NCBI]
|
6.9516e-07
|
|
|
HDAC1
|
[NCBI]
|
6.90954e-07
|
|
|
PC
|
[NCBI]
|
6.90954e-07
|
|
|
CASR
|
[NCBI]
|
6.87977e-07
|
|
|
PAEP
|
[NCBI]
|
6.68462e-07
|
|
|
AIRE
|
[NCBI]
|
6.68462e-07
|
|
|
TCRG
|
[NCBI]
|
6.43676e-07
|
|
|
CTLA4
|
[NCBI]
|
6.43676e-07
|
|
|
FOLH1
|
[NCBI]
|
6.43676e-07
|
|
|
HLA-DRA
|
[NCBI]
|
6.43676e-07
|
|
|
WBS
|
[NCBI]
|
6.35562e-07
|
|
|
MTM1
|
[NCBI]
|
6.26529e-07
|
|
|
ED1
|
[NCBI]
|
6.26529e-07
|
|
|
PG
|
[NCBI]
|
6.03879e-07
|
|
|
SI
|
[NCBI]
|
6.03879e-07
|
|
|
PIGR
|
[NCBI]
|
6.03879e-07
|
|
|
DSTN
|
[NCBI]
|
5.91055e-07
|
|
|
BRAF
|
[NCBI]
|
5.91055e-07
|
|
|
PJS
|
[NCBI]
|
5.89569e-07
|
|
|
SLC6A3
|
[NCBI]
|
5.7811e-07
|
|
|
SCD
|
[NCBI]
|
5.67965e-07
|
|
|
VWS
|
[NCBI]
|
5.42432e-07
|
|
|
POLG
|
[NCBI]
|
5.41439e-07
|
|
|
USF1
|
[NCBI]
|
5.41439e-07
|
|
|
VIM
|
[NCBI]
|
4.94777e-07
|
|
|
DAZ
|
[NCBI]
|
4.94698e-07
|
|
|
tyrosinemia, type i
|
[NCBI]
|
4.94698e-07
|
|
|
ZNF145
|
[NCBI]
|
4.94698e-07
|
|
|
ADCYAP1
|
[NCBI]
|
4.93478e-07
|
|
|
GUSB
|
[NCBI]
|
4.77378e-07
|
|
|
SRY
|
[NCBI]
|
4.68814e-07
|
|
|
NSF
|
[NCBI]
|
4.68814e-07
|
|
|
TYR
|
[NCBI]
|
4.68814e-07
|
|
|
MAPK14
|
[NCBI]
|
4.50711e-07
|
|
|
RELN
|
[NCBI]
|
4.50711e-07
|
|
|
ABCA1
|
[NCBI]
|
4.09361e-07
|
|
|
APCS
|
[NCBI]
|
4.09361e-07
|
|
|
IFNG
|
[NCBI]
|
4.09361e-07
|
|
|
TNFRSF6
|
[NCBI]
|
4.09361e-07
|
|
|
DMPK
|
[NCBI]
|
4.09361e-07
|
|
|
CTSC
|
[NCBI]
|
4.09361e-07
|
|
|
TSC1
|
[NCBI]
|
4.09361e-07
|
|
|
PTGS2
|
[NCBI]
|
3.94239e-07
|
|
|
COL7A1
|
[NCBI]
|
3.70542e-07
|
|
|
FPGS
|
[NCBI]
|
3.47394e-07
|
|
|
AKT1
|
[NCBI]
|
3.34151e-07
|
|
|
AANAT
|
[NCBI]
|
3.34151e-07
|
|
|
FGF23
|
[NCBI]
|
3.34151e-07
|
|
|
SERPINA6
|
[NCBI]
|
3.33185e-07
|
|
|
ARMD1
|
[NCBI]
|
3.31169e-07
|
|
|
CPE
|
[NCBI]
|
3.24867e-07
|
|
|
NP
|
[NCBI]
|
3.00095e-07
|
|
|
CACNA1A
|
[NCBI]
|
3.00095e-07
|
|
|
BCR
|
[NCBI]
|
2.81805e-07
|
|
|
ABCC2
|
[NCBI]
|
2.81667e-07
|
|
|
DAO
|
[NCBI]
|
2.68283e-07
|
|
|
HS
|
[NCBI]
|
2.68283e-07
|
|
|
MPZ
|
[NCBI]
|
2.6102e-07
|
|
|
MEN1
|
[NCBI]
|
2.6102e-07
|
|
|
WRN
|
[NCBI]
|
2.50861e-07
|
|
|
PSAP
|
[NCBI]
|
2.3863e-07
|
|
|
TCOF
|
[NCBI]
|
2.22136e-07
|
|
|
SMN1
|
[NCBI]
|
2.21697e-07
|
|
|
UNG
|
[NCBI]
|
2.11057e-07
|
|
|
BLM
|
[NCBI]
|
2.10426e-07
|
|
|
CGD
|
[NCBI]
|
2.10426e-07
|
|
|
CDK4
|
[NCBI]
|
1.9742e-07
|
|
|
thrombasthenia of glanzmann and naegeli
|
[NCBI]
|
1.73247e-07
|
|
|
SLC18A2
|
[NCBI]
|
1.61851e-07
|
|
|
KIT
|
[NCBI]
|
1.61851e-07
|
|
|
MYH7
|
[NCBI]
|
1.61851e-07
|
|
|
INSL3
|
[NCBI]
|
1.61851e-07
|
|
|
panencephalitis, subacute sclerosing
|
[NCBI]
|
1.4766e-07
|
|
|
UCP2
|
[NCBI]
|
1.40827e-07
|
|
|
PARG
|
[NCBI]
|
1.40078e-07
|
|
|
DFFB
|
[NCBI]
|
1.20106e-07
|
|
|
PTK2B
|
[NCBI]
|
1.06329e-07
|
|
|
TD1
|
[NCBI]
|
1.0207e-07
|
|
|
MYC
|
[NCBI]
|
9.28919e-08
|
|
|
MCP
|
[NCBI]
|
8.55993e-08
|
|
|
SLC6A4
|
[NCBI]
|
8.53981e-08
|
|
|
STAT6
|
[NCBI]
|
8.02686e-08
|
|
|
TERT
|
[NCBI]
|
7.66579e-08
|
|
|
KCNQ1
|
[NCBI]
|
7.03943e-08
|
|
|
factor v deficiency
|
[NCBI]
|
6.8479e-08
|
|
|
BSG
|
[NCBI]
|
6.8479e-08
|
|
|
CCD
|
[NCBI]
|
5.88293e-08
|
|
|
dystrophia myotonica 1
|
[NCBI]
|
5.75176e-08
|
|
|
KRAS
|
[NCBI]
|
5.7042e-08
|
|
|
HRAS
|
[NCBI]
|
5.7042e-08
|
|
|
velocardiofacial syndrome
|
[NCBI]
|
4.88463e-08
|
|
|
LPI
|
[NCBI]
|
4.88463e-08
|
|
|
IDUA
|
[NCBI]
|
4.74818e-08
|
|
|
GAPDH
|
[NCBI]
|
4.39057e-08
|
|
|
breast cancer
|
[NCBI]
|
3.92653e-08
|
|
|
PTEN
|
[NCBI]
|
3.89589e-08
|
|
|
MTTL1
|
[NCBI]
|
3.83166e-08
|
|
|
CEACAM1
|
[NCBI]
|
3.48608e-08
|
|
|
metachromatic leukodystrophy
|
[NCBI]
|
2.9775e-08
|
|
|
DNTT
|
[NCBI]
|
2.59389e-08
|
|
|
PARP1
|
[NCBI]
|
2.2765e-08
|
|
|
SOD1
|
[NCBI]
|
2.1499e-08
|
|
|
JAK3
|
[NCBI]
|
1.84043e-08
|
|
|
SPARC
|
[NCBI]
|
1.84043e-08
|
|
|
STAT5A
|
[NCBI]
|
1.75732e-08
|
|
|
ADA
|
[NCBI]
|
1.70591e-08
|
|
|
XIST
|
[NCBI]
|
1.64261e-08
|
|
|
PARK2
|
[NCBI]
|
1.64261e-08
|
|
|
CMT1A
|
[NCBI]
|
1.55243e-08
|
|
|
LIPC
|
[NCBI]
|
1.22156e-08
|
|
|
NMU
|
[NCBI]
|
1.22156e-08
|
|
|
PMD
|
[NCBI]
|
1.19079e-08
|
|
|
PAX6
|
[NCBI]
|
1.10781e-08
|
|
|
TP53
|
[NCBI]
|
9.51529e-09
|
|
|
XDH
|
[NCBI]
|
8.60574e-09
|
|
|
CCL17
|
[NCBI]
|
7.33327e-09
|
|
|
CTNNB1
|
[NCBI]
|
3.71938e-09
|
|
|
THRB
|
[NCBI]
|
3.46053e-09
|
|
|
LOX
|
[NCBI]
|
3.46053e-09
|
|
|
APOD
|
[NCBI]
|
1.33772e-09
|
|
|
DSPP
|
[NCBI]
|
1.33772e-09
|
|
|
REG3A
|
[NCBI]
|
1.33772e-09
|
|
|
TSC2
|
[NCBI]
|
1.24624e-09
|
|
|
H6PD
|
[NCBI]
|
1.24624e-09
|
|
|
ALS1
|
[NCBI]
|
9.07752e-10
|
|
|
IL10
|
[NCBI]
|
1.33727e-10
|
|